{"ref-id":"A11627","pubmed-id":10036158,"citation":"Maingonnat C, Victor R, Bertrand P, Courel MN, Maunoury R, Delpech B: Activation and inhibition of human cancer cell hyaluronidase by proteins. Anal Biochem. 1999 Mar 1;268(1):30-4.","parent_key":"BE0000530"}
{"ref-id":"A11628","pubmed-id":10466114,"citation":"Parameswaran S, Brown LV, Ibbott GS, Lai-Fook SJ: Effect of concentration and hyaluronidase on albumin diffusion across rabbit mesentery. Microcirculation. 1999 Jun;6(2):117-26.","parent_key":"BE0000530"}
{"ref-id":"A192021","pubmed-id":12090938,"citation":"Lozinsky E, Novoselsky A, Glaser R, Shames AI, Likhtenshtein GI, Meyerstein D: Effect of ionic strength on the binding of ascorbate to albumin. Biochim Biophys Acta. 2002 Jul 3;1571(3):239-44. doi: 10.1016/s0304-4165(02)00257-x.","parent_key":"BE0000530"}
{"ref-id":"A192024","pubmed-id":6735617,"citation":"Oelrichs BA, Kratzing CC, Kelly JD, Winzor DJ: The binding of ascorbate to bovine serum albumin. Int J Vitam Nutr Res. 1984;54(1):61-4.","parent_key":"BE0000530"}
{"ref-id":"A11676","pubmed-id":16678417,"citation":"Zsila F, Nadolski G, Lockwood SF: Association studies of aggregated aqueous lutein diphosphate with human serum albumin and alpha1-acid glycoprotein in vitro: evidence from circular dichroism and electronic absorption spectroscopy. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3797-801. Epub 2006 May 5.","parent_key":"BE0000530"}
{"ref-id":"A11677","pubmed-id":11273666,"citation":"Yemelyanov AY, Katz NB, Bernstein PS: Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res. 2001 Apr;72(4):381-92.","parent_key":"BE0000530"}
{"ref-id":"A192381","pubmed-id":26372107,"citation":"Hosseinzadeh R, Khorsandi K: Interaction of vitamin B1 with bovine serum albumin investigation using vitamin B1-selective electrode: potentiometric and molecular modeling study. J Biomol Struct Dyn. 2016 Sep;34(9):1903-10. doi: 10.1080/07391102.2015.1094414. Epub 2016 May 4.","parent_key":"BE0000530"}
{"ref-id":"A192384","pubmed-id":3733341,"citation":"Thom JY, Davis RE, Icke GC: Protein binding of thiamin in human plasma. Int J Vitam Nutr Res. 1986;56(2):189.","parent_key":"BE0000530"}
{"ref-id":"A20242","pubmed-id":25451573,"citation":"Pavicevic ID, Jovanovic VB, Takic MM, Penezic AZ, Acimovic JM, Mandic LM: Fatty acids binding to human serum albumin: Changes of reactivity and glycation level of Cysteine-34 free thiol group with methylglyoxal. Chem Biol Interact. 2014 Dec 5;224:42-50. doi: 10.1016/j.cbi.2014.10.008. Epub 2014 Oct 17.","parent_key":"BE0000530"}
{"ref-id":"A19989","pubmed-id":17217919,"citation":"Karnaukhova E: Interactions of human serum albumin with retinoic acid, retinal and retinyl acetate. Biochem Pharmacol. 2007 Mar 15;73(6):901-10. Epub 2006 Dec 2.","parent_key":"BE0000530"}
{"ref-id":"A192465","pubmed-id":30037155,"citation":"Parra M, Stahl S, Hellmann H: Vitamin B(6) and Its Role in Cell Metabolism and Physiology. Cells. 2018 Jul 22;7(7). pii: cells7070084. doi: 10.3390/cells7070084.","parent_key":"BE0000530"}
{"ref-id":"A192468","pubmed-id":1898027,"citation":"Fonda ML, Trauss C, Guempel UM: The binding of pyridoxal 5'-phosphate to human serum albumin. Arch Biochem Biophys. 1991 Jul;288(1):79-86. doi: 10.1016/0003-9861(91)90167-h.","parent_key":"BE0000530"}
{"ref-id":"A174475","pubmed-id":9474471,"citation":"Knauf H, Mutschler E: Clinical pharmacokinetics and pharmacodynamics of torasemide. Clin Pharmacokinet. 1998 Jan;34(1):1-24. doi: 10.2165/00003088-199834010-00001.","parent_key":"BE0000530"}
{"ref-id":"A19948","pubmed-id":15814459,"citation":"Bocedi A, Notaril S, Narciso P, Bolli A, Fasano M, Ascenzi P: Binding of anti-HIV drugs to human serum albumin. IUBMB Life. 2004 Oct;56(10):609-14.","parent_key":"BE0000530"}
{"ref-id":"A19949","pubmed-id":16336266,"citation":"Bocedi A, Notari S, Menegatti E, Fanali G, Fasano M, Ascenzi P: Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin. FEBS J. 2005 Dec;272(24):6287-96.","parent_key":"BE0000530"}
{"ref-id":"A174583","pubmed-id":9160173,"citation":"Lennernas H, Fager G: Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005.","parent_key":"BE0000530"}
{"ref-id":"A15479","pubmed-id":15791110,"citation":"Liu R, Eckenhoff RG: Weak polar interactions confer albumin binding site selectivity for haloether anesthetics. Anesthesiology. 2005 Apr;102(4):799-805.","parent_key":"BE0000530"}
{"ref-id":"A15480","pubmed-id":15449957,"citation":"Sawas AH, Pentyala SN, Rebecchi MJ: Binding of volatile anesthetics to serum albumin: measurements of enthalpy and solvent contributions. Biochemistry. 2004 Oct 5;43(39):12675-85.","parent_key":"BE0000530"}
{"ref-id":"A202121","pubmed-id":6721962,"citation":"Dale O, Nilsen OG: Displacement of some basic drugs from human serum proteins by enflurane, halothane and their major metabolites. An in vitro study. Br J Anaesth. 1984 May;56(5):535-42. doi: 10.1093/bja/56.5.535.","parent_key":"BE0000530"}
{"ref-id":"A202028","pubmed-id":13175102,"citation":"GOLDBAUM LR, SMITH PK: The interaction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions. J Pharmacol Exp Ther. 1954 Jun;111(2):197-209.","parent_key":"BE0000530"}
{"ref-id":"A175030","pubmed-id":16717165,"citation":"Chaitman BR: Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006 May 23;113(20):2462-72. doi: 10.1161/CIRCULATIONAHA.105.597500.","parent_key":"BE0000925"}
{"ref-id":"A190594","pubmed-id":31400341,"citation":"Uzelac TN, Nikolic-Kokic AL, Spasic SD, Macvanin MT, Nikolic MR, Mandic LM, Jovanovic VB: Opposite clozapine and ziprasidone effects on the reactivity of plasma albumin SH-group are the consequence of their different binding properties dependent on protein fatty acids content. Chem Biol Interact. 2019 Sep 25;311:108787. doi: 10.1016/j.cbi.2019.108787. Epub 2019 Aug 7.","parent_key":"BE0000530"}
{"ref-id":"A190597","pubmed-id":28539955,"citation":"Lv D, Zhao M, Chen L, Yu D, Yun X, Yang Q, Huang X: An Inter-Ethnic Comparison Study of Ziprasidone Plasma Levels, Dosage and Clinical Response in Patients with Schizophrenia. Psychiatry Investig. 2017 May;14(3):360-367. doi: 10.4306/pi.2017.14.3.360. Epub 2017 May 16.","parent_key":"BE0000925"}
{"ref-id":"A15482","pubmed-id":15282104,"citation":"Chen J, Ohnmacht C, Hage DS: Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 25;809(1):137-45.","parent_key":"BE0000530"}
{"ref-id":"A15483","pubmed-id":16621742,"citation":"Ohnmacht CM, Chen S, Tong Z, Hage DS: Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19;836(1-2):83-91. Epub 2006 Apr 18.","parent_key":"BE0000530"}
{"ref-id":"A188790","pubmed-id":22479078,"citation":"Co M, Lo A: Effect of albumin on phenytoin concentration: are we flogging a dead horse? Can J Hosp Pharm. 2011 Jul;64(4):293. doi: 10.4212/cjhp.v64i4.1051.","parent_key":"BE0000530"}
{"ref-id":"A175141","pubmed-id":30422518,"citation":"Morris J, Dunham A: Metoprolol .","parent_key":"BE0000530"}
{"ref-id":"A20268","pubmed-id":1376777,"citation":"Rahman MH, Miyoshi T, Sukimoto K, Takadate A, Otagiri M: Interaction mode of dicumarol and its derivatives with human serum albumin, alpha 1-acid glycoprotein and asialo alpha 1-acid glycoprotein. J Pharmacobiodyn. 1992 Jan;15(1):7-16.","parent_key":"BE0000530"}
{"ref-id":"A33728","pubmed-id":15355124,"citation":"Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S: Pharmacokinetic interactions of topiramate. Clin Pharmacokinet. 2004;43(12):763-80. doi: 10.2165/00003088-200443120-00001.","parent_key":"BE0000530"}
{"ref-id":"A12629","pubmed-id":3339510,"citation":"Robertson A, Fink S, Karp W: Effect of cephalosporins on bilirubin-albumin binding. J Pediatr. 1988 Feb;112(2):291-4.","parent_key":"BE0000530"}
{"ref-id":"A15458","pubmed-id":12553433,"citation":"Palha JA: Transthyretin as a thyroid hormone carrier: function revisited. Clin Chem Lab Med. 2002 Dec;40(12):1292-300.","parent_key":"BE0000530"}
{"ref-id":"A11790","pubmed-id":10322928,"citation":"Chu JS, Kishion S, Nomura A, Miyazaki K: Serum alpha 1-acid glycoprotein, sialic acid, and protein binding of disopyramide in normal subjects and cardiac patients. Zhongguo Yao Li Xue Bao. 1997 Sep;18(5):408-10.","parent_key":"BE0000925"}
{"ref-id":"A11791","pubmed-id":10824133,"citation":"Hanada K, Ohta T, Hirai M, Arai M, Ogata H: Enantioselective binding of propranolol, disopyramide, and verapamil to human alpha(1)-acid glycoprotein. J Pharm Sci. 2000 Jun;89(6):751-7.","parent_key":"BE0000925"}
{"ref-id":"A11792","pubmed-id":14616427,"citation":"Nakagawa T, Kishino S, Itoh S, Sugawara M, Miyazaki K: Differential binding of disopyramide and warfarin enantiomers to human alpha(1)-acid glycoprotein variants. Br J Clin Pharmacol. 2003 Dec;56(6):664-9.","parent_key":"BE0000925"}
{"ref-id":"A11793","pubmed-id":2860235,"citation":"Haughey DB, Steinberg I, Lee MH: Protein binding of disopyramide--displacement by mono-N-dealkyldisopyramide and variation with source of alpha-1-acid glycoprotein. J Pharm Pharmacol. 1985 Apr;37(4):285-8.","parent_key":"BE0000925"}
{"ref-id":"A11794","pubmed-id":2862237,"citation":"Brunner F, Muller WE: Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid. J Pharm Pharmacol. 1985 May;37(5):305-9.","parent_key":"BE0000925"}
{"ref-id":"A38238","pubmed-id":24715748,"citation":"Cada DJ, Baker DE: Conjugated estrogens and bazedoxifene. Hosp Pharm. 2014 Mar;49(3):273-83. doi: 10.1310/hpj4903-273.","parent_key":"BE0000530"}
{"ref-id":"A175750","pubmed-id":24732041,"citation":"Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B: A review of atomoxetine effects in young people with developmental disabilities. Res Dev Disabil. 2014 Jun;35(6):1412-24. doi: 10.1016/j.ridd.2014.03.006. Epub 2014 Apr 16.","parent_key":"BE0000530"}
{"ref-id":"A175723","pubmed-id":27721971,"citation":"Hutchison SL, Ghuman JK, Ghuman HS, Karpov I, Schuster JM: Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review. Ther Adv Psychopharmacol. 2016 Oct;6(5):317-334. doi: 10.1177/2045125316647686. Epub 2016 May 20.","parent_key":"BE0000530"}
{"ref-id":"A175723","pubmed-id":27721971,"citation":"Hutchison SL, Ghuman JK, Ghuman HS, Karpov I, Schuster JM: Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review. Ther Adv Psychopharmacol. 2016 Oct;6(5):317-334. doi: 10.1177/2045125316647686. Epub 2016 May 20.","parent_key":"BE0004879"}
{"ref-id":"A175750","pubmed-id":24732041,"citation":"Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B: A review of atomoxetine effects in young people with developmental disabilities. Res Dev Disabil. 2014 Jun;35(6):1412-24. doi: 10.1016/j.ridd.2014.03.006. Epub 2014 Apr 16.","parent_key":"BE0004879"}
{"ref-id":"A191823","pubmed-id":22025496,"citation":"Zhou R, Perez-Aguilar JM, Meng Q, Saven JG, Liu R: Opioid binding sites in human serum albumin. Anesth Analg. 2012 Jan;114(1):122-8. doi: 10.1213/ANE.0b013e318232e922. Epub 2011 Oct 24.","parent_key":"BE0000530"}
{"ref-id":"A20284","pubmed-id":8946661,"citation":"Dasgupta A, Emerson L: Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: lack of interaction in uremic sera due to the presence of endogenous factors. Ther Drug Monit. 1996 Dec;18(6):654-9.","parent_key":"BE0000530"}
{"ref-id":"A187241","pubmed-id":6491906,"citation":"Morris ME, Levy G: Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. J Pharm Sci. 1984 Aug;73(8):1038-41. doi: 10.1002/jps.2600730806.","parent_key":"BE0000530"}
{"ref-id":"A15487","pubmed-id":6108517,"citation":"Brinkschulte M, Breyer-Pfaff U: The contribution of alpha 1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man. Naunyn Schmiedebergs Arch Pharmacol. 1980 Oct;314(1):61-6. doi: 10.1007/bf00498432.","parent_key":"BE0000530"}
{"ref-id":"A15488","pubmed-id":17125386,"citation":"Banerjee T, Singh SK, Kishore N: Binding of naproxen and amitriptyline to bovine serum albumin: biophysical aspects. J Phys Chem B. 2006 Nov 30;110(47):24147-56.","parent_key":"BE0000530"}
{"ref-id":"A15487","pubmed-id":6108517,"citation":"Brinkschulte M, Breyer-Pfaff U: The contribution of alpha 1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man. Naunyn Schmiedebergs Arch Pharmacol. 1980 Oct;314(1):61-6. doi: 10.1007/bf00498432.","parent_key":"BE0000925"}
{"ref-id":"A15489","pubmed-id":2870173,"citation":"Ferry DG, Caplan NB, Cubeddu LX: Interaction between antidepressants and alpha 1-adrenergic receptor antagonists on the binding to alpha 1-acid glycoprotein. J Pharm Sci. 1986 Feb;75(2):146-9. doi: 10.1002/jps.2600750208.","parent_key":"BE0000925"}
{"ref-id":"A176468","pubmed-id":29261877,"citation":"Abi-Aad KR, Derian A: Hydromorphone .","parent_key":"BE0000530"}
{"ref-id":"A12195","pubmed-id":9275312,"citation":"Bertucci C, Wainer IW: Improved chromatographic performance of a modified human albumin based stationary phase. Chirality. 1997;9(4):335-40.","parent_key":"BE0000530"}
{"ref-id":"A497","pubmed-id":12405865,"citation":"Eap CB, Buclin T, Baumann P: Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002;41(14):1153-93. doi: 10.2165/00003088-200241140-00003.","parent_key":"BE0000925"}
{"ref-id":"A185234","pubmed-id":30205091,"citation":"Volpe DA, Xu Y, Sahajwalla CG, Younis IR, Patel V: Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review. J Pharm Sci. 2018 Dec;107(12):2983-2991. doi: 10.1016/j.xphs.2018.08.025. Epub 2018 Sep 8.","parent_key":"BE0000925"}
{"ref-id":"A497","pubmed-id":12405865,"citation":"Eap CB, Buclin T, Baumann P: Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002;41(14):1153-93. doi: 10.2165/00003088-200241140-00003.","parent_key":"BE0000530"}
{"ref-id":"A185234","pubmed-id":30205091,"citation":"Volpe DA, Xu Y, Sahajwalla CG, Younis IR, Patel V: Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review. J Pharm Sci. 2018 Dec;107(12):2983-2991. doi: 10.1016/j.xphs.2018.08.025. Epub 2018 Sep 8.","parent_key":"BE0000530"}
{"ref-id":"A14767","pubmed-id":10511917,"citation":"Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM: Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet. 1999 Sep;37(3):177-93.","parent_key":"BE0000530"}
{"ref-id":"A177014","pubmed-id":30422498,"citation":"Thomas K, Saadabadi A: Olanzapine .","parent_key":"BE0000530"}
{"ref-id":"A14767","pubmed-id":10511917,"citation":"Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM: Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet. 1999 Sep;37(3):177-93.","parent_key":"BE0000925"}
{"ref-id":"A177014","pubmed-id":30422498,"citation":"Thomas K, Saadabadi A: Olanzapine .","parent_key":"BE0000925"}
{"ref-id":"A178210","pubmed-id":29630759,"citation":"Niaei N, Hasanzadeh M, Shadjou N: Molecular interaction of some cardiovascular drugs with human serum albumin at physiological-like conditions: A new approach. J Mol Recognit. 2018 Aug;31(8):e2715. doi: 10.1002/jmr.2715. Epub 2018 Apr 6.","parent_key":"BE0000530"}
{"ref-id":"A177922","pubmed-id":25300043,"citation":"Dangkoob F, Housaindokht MR, Asoodeh A, Rajabi O, Rouhbakhsh Zaeri Z, Verdian Doghaei A: Spectroscopic and molecular modeling study on the separate and simultaneous bindings of alprazolam and fluoxetine hydrochloride to human serum albumin (HSA): with the aim of the drug interactions probing. Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 25;137:1106-19. doi: 10.1016/j.saa.2014.08.149. Epub 2014 Oct 7.","parent_key":"BE0000530"}
{"ref-id":"A177925","pubmed-id":8513649,"citation":"Greenblatt DJ, Wright CE: Clinical pharmacokinetics of alprazolam. Therapeutic implications. Clin Pharmacokinet. 1993 Jun;24(6):453-71. doi: 10.2165/00003088-199324060-00003.","parent_key":"BE0004879"}
{"ref-id":"A20110","pubmed-id":20435530,"citation":"Joseph KS, Hage DS: Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 1;878(19):1590-8. doi: 10.1016/j.jchromb.2010.04.019.","parent_key":"BE0000530"}
{"ref-id":"A20139","pubmed-id":20829128,"citation":"Joseph KS, Anguizola J, Jackson AJ, Hage DS: Chromatographic analysis of acetohexamide binding to glycated human serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2775-81. doi:  10.1016/j.jchromb.2010.08.021. Epub 2010 Aug 21.","parent_key":"BE0000530"}
{"ref-id":"A20111","pubmed-id":20956006,"citation":"Yoo MJ, Hage DS: Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.","parent_key":"BE0000530"}
{"ref-id":"A20112","pubmed-id":20974553,"citation":"Basiaga SB, Hage DS: Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 15;878(30):3193-7. doi: 10.1016/j.jchromb.2010.09.033. Epub 2010 Oct 23.","parent_key":"BE0000530"}
{"ref-id":"A20140","pubmed-id":21612784,"citation":"Tong Z, Joseph KS, Hage DS: Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography. J Chromatogr A. 2011 Dec 9;1218(49):8915-24. doi: 10.1016/j.chroma.2011.04.078. Epub 2011 May 6.","parent_key":"BE0000530"}
{"ref-id":"A15505","pubmed-id":1031216,"citation":"Bratlid D, Bergan T: Displacement of albumin-bound antimicrobial agents by bilirubin. Pharmacology. 1976;14(5):464-72.","parent_key":"BE0000530"}
{"ref-id":"A178126","pubmed-id":9144743,"citation":"Takamura N, Maruyama T, Ahmed S, Suenaga A, Otagiri M: Interactions of aldosterone antagonist diuretics with human serum proteins. Pharm Res. 1997 Apr;14(4):522-6.","parent_key":"BE0000530"}
{"ref-id":"A178126","pubmed-id":9144743,"citation":"Takamura N, Maruyama T, Ahmed S, Suenaga A, Otagiri M: Interactions of aldosterone antagonist diuretics with human serum proteins. Pharm Res. 1997 Apr;14(4):522-6.","parent_key":"BE0004879"}
{"ref-id":"A16718","pubmed-id":1686912,"citation":"Ohshima T, Hasegawa T, Johno I, Kitazawa S: Protein binding of cefpiramide in the plasma of various species. J Pharm Pharmacol. 1991 Nov;43(11):805-6.","parent_key":"BE0000530"}
{"ref-id":"A192168","pubmed-id":29568666,"citation":"Pontremoli C, Barbero N, Viscardi G, Visentin S: Insight into the interaction of inhaled corticosteroids with human serum albumin: A spectroscopic-based study. J Pharm Anal. 2018 Feb;8(1):37-44. doi: 10.1016/j.jpha.2017.07.003. Epub 2017 Jul 5.","parent_key":"BE0000530"}
{"ref-id":"A17236","pubmed-id":6754208,"citation":"Edwards DJ, Svensson CK, Visco JP, Lalka D: Clinical pharmacokinetics of pethidine: 1982. Clin Pharmacokinet. 1982 Sep-Oct;7(5):421-33.","parent_key":"BE0000530"}
{"ref-id":"A17236","pubmed-id":6754208,"citation":"Edwards DJ, Svensson CK, Visco JP, Lalka D: Clinical pharmacokinetics of pethidine: 1982. Clin Pharmacokinet. 1982 Sep-Oct;7(5):421-33.","parent_key":"BE0000925"}
{"ref-id":"A16860","pubmed-id":1625169,"citation":"Terasaki T, Nouda H, Tsuji A: Selective analysis of mutual displacement effects at the primary binding sites of phenoxymethylpenicillin and cephalothin bindings to human serum albumin. J Pharmacobiodyn. 1992 Mar;15(3):91-7.","parent_key":"BE0000530"}
{"ref-id":"A176705","pubmed-id":2748545,"citation":"Sager G, Jaeger R, Little C: Binding of prazosin to alpha 1-acid glycoprotein and albumin: effect of protein purity and concentrations. Pharmacol Toxicol. 1989 Apr;64(4):365-8.","parent_key":"BE0000925"}
{"ref-id":"A11851","pubmed-id":1449542,"citation":"Urien S, Claudepierre P, Meyer J, Brandt R, Tillement JP: Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes. Biochem Pharmacol. 1992 Nov 3;44(9):1891-3.","parent_key":"BE0000530"}
{"ref-id":"A11852","pubmed-id":15902381,"citation":"Preiss JC, Zouboulis CC, Zeitz M, Duchmann R: [Severe erythrodermic psoriasis in a patient with 22q11 deletion syndrome]. Med Klin (Munich). 2005 May 13;100(5):275-8.","parent_key":"BE0000530"}
{"ref-id":"A11853","pubmed-id":2146977,"citation":"Carillet V, Morliere P, Maziere JC, Huppe G, Santus R, Dubertret L: In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin. Biochim Biophys Acta. 1990 Nov 12;1055(2):98-101.","parent_key":"BE0000530"}
{"ref-id":"A178903","pubmed-id":9435990,"citation":"Davies NM: Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition? Clin Pharmacokinet. 1997 Dec;33(6):404-16. doi: 10.2165/00003088-199733060-00001.","parent_key":"BE0000530"}
{"ref-id":"A14807","pubmed-id":21366359,"citation":"Knadler MP, Lobo E, Chappell J, Bergstrom R: Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011 May;50(5):281-94. doi: 10.2165/11539240-000000000-00000.","parent_key":"BE0000530"}
{"ref-id":"A14807","pubmed-id":21366359,"citation":"Knadler MP, Lobo E, Chappell J, Bergstrom R: Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011 May;50(5):281-94. doi: 10.2165/11539240-000000000-00000.","parent_key":"BE0004879"}
{"ref-id":"A15484","pubmed-id":16819214,"citation":"Kitamura K, Omran AA, Nagata C, Kamijima Y, Tanaka R, Takegami S, Kitade T: Effects of inorganic ions on the binding of triflupromazine and chlorpromazine to bovine serum albumin studied by spectrometric methods. Chem Pharm Bull (Tokyo). 2006 Jul;54(7):972-6.","parent_key":"BE0000530"}
{"ref-id":"A15485","pubmed-id":11559920,"citation":"Rukhadze MD, Bezarashvili GS, Sidamonidze NS, Tsagareli SK: Investigation of binding process of chlorpromazine to bovine serum albumin by means of passive and active experiments. Biomed Chromatogr. 2001 Oct;15(6):365-73.","parent_key":"BE0000530"}
{"ref-id":"A15486","pubmed-id":15264002,"citation":"Silva D, Cortez CM, Louro SR: Quenching of the intrinsic fluorescence of bovine serum albumin by chlorpromazine and hemin. Braz J Med Biol Res. 2004 Jul;37(7):963-8. Epub 2004 Jun 22.","parent_key":"BE0000530"}
{"ref-id":"A180991","pubmed-id":3041384,"citation":"Jann MW: Buspirone: an update on a unique anxiolytic agent. Pharmacotherapy. 1988;8(2):100-16.","parent_key":"BE0000530"}
{"ref-id":"A180991","pubmed-id":3041384,"citation":"Jann MW: Buspirone: an update on a unique anxiolytic agent. Pharmacotherapy. 1988;8(2):100-16.","parent_key":"BE0000925"}
{"ref-id":"A15511","pubmed-id":11689002,"citation":"Quevedo MA, Moroni GN, Brinon MC: Human serum albumin binding of novel antiretroviral nucleoside derivatives of AZT. Biochem Biophys Res Commun. 2001 Nov 9;288(4):954-60.","parent_key":"BE0000530"}
{"ref-id":"A18203","pubmed-id":8249052,"citation":"Leow KP, Wright AW, Cramond T, Smith MT: Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit. 1993 Oct;15(5):440-7.","parent_key":"BE0000530"}
{"ref-id":"A18203","pubmed-id":8249052,"citation":"Leow KP, Wright AW, Cramond T, Smith MT: Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit. 1993 Oct;15(5):440-7.","parent_key":"BE0004879"}
{"ref-id":"A20270","pubmed-id":8027947,"citation":"Ojingwa JC, Spahn-Langguth H, Benet LZ: Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma. J Pharmacokinet Biopharm. 1994 Feb;22(1):19-40.","parent_key":"BE0000530"}
{"ref-id":"A20276","pubmed-id":9353694,"citation":"Borga O, Borga B: Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study. J Pharmacokinet Biopharm. 1997 Feb;25(1):63-77.","parent_key":"BE0000530"}
{"ref-id":"A18349","pubmed-id":19164148,"citation":"Baneres-Roquet F, Gualtieri M, Villain-Guillot P, Pugniere M, Leonetti JP: Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions. Antimicrob Agents Chemother. 2009 Apr;53(4):1528-31. doi: 10.1128/AAC.00971-08. Epub 2009 Jan 21.","parent_key":"BE0000530"}
{"ref-id":"A18349","pubmed-id":19164148,"citation":"Baneres-Roquet F, Gualtieri M, Villain-Guillot P, Pugniere M, Leonetti JP: Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions. Antimicrob Agents Chemother. 2009 Apr;53(4):1528-31. doi: 10.1128/AAC.00971-08. Epub 2009 Jan 21.","parent_key":"BE0004879"}
{"ref-id":"A20003","pubmed-id":16773208,"citation":"Khalaila I, Bergamo A, Bussy F, Sava G, Dyson PJ: The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy. Int J Oncol. 2006 Jul;29(1):261-8.","parent_key":"BE0000530"}
{"ref-id":"A178894","pubmed-id":24913236,"citation":"Varshney A, Ansari Y, Zaidi N, Ahmad E, Badr G, Alam P, Khan RH: Analysis of binding interaction between antibacterial ciprofloxacin and human serum albumin by spectroscopic techniques. Cell Biochem Biophys. 2014 Sep;70(1):93-101. doi: 10.1007/s12013-014-9863-1.","parent_key":"BE0000530"}
{"ref-id":"A191092","pubmed-id":7094510,"citation":"Pike E, Skuterud B: Plasma binding variations of amitriptyline and nortriptyline. Clin Pharmacol Ther. 1982 Aug;32(2):228-34. doi: 10.1038/clpt.1982.152.","parent_key":"BE0000530"}
{"ref-id":"A191092","pubmed-id":7094510,"citation":"Pike E, Skuterud B: Plasma binding variations of amitriptyline and nortriptyline. Clin Pharmacol Ther. 1982 Aug;32(2):228-34. doi: 10.1038/clpt.1982.152.","parent_key":"BE0000925"}
{"ref-id":"A15495","pubmed-id":15150801,"citation":"Sulkowska A, Bojko B, Rownicka J, Sulkowski W: Competition of drugs to serum albumin in combination therapy. Biopolymers. 2004 Jun 15;74(3):256-62.","parent_key":"BE0000530"}
{"ref-id":"A15496","pubmed-id":8573632,"citation":"Bertucci C, Ascoli G, Uccello-Barretta G, Di Bari L, Salvadori P: The binding of 5-fluorouracil to native and modified human serum albumin: UV, CD, and 1H and 19F NMR investigation. J Pharm Biomed Anal. 1995 Aug;13(9):1087-93.","parent_key":"BE0000530"}
{"ref-id":"A191362","pubmed-id":27951518,"citation":"Poureshghi F, Ghandforoushan P, Safarnejad A, Soltani S: Interaction of an antiepileptic drug, lamotrigine with human serum albumin (HSA): Application of spectroscopic techniques and molecular modeling methods. J Photochem Photobiol B. 2017 Jan;166:187-192. doi: 10.1016/j.jphotobiol.2016.09.046. Epub 2016 Nov 5.","parent_key":"BE0000530"}
{"ref-id":"A189702","pubmed-id":17605150,"citation":"Martinez-Gomez MA, Villanueva-Camanas RM, Sagrado S, Medina-Hernandez MJ: Evaluation of enantioselective binding of antihistamines to human serum albumin by ACE. Electrophoresis. 2007 Aug;28(15):2635-43. doi: 10.1002/elps.200600742.","parent_key":"BE0000530"}
{"ref-id":"A15419","pubmed-id":17628030,"citation":"Warnecke A, Fichtner I, Sass G, Kratz F: Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B. Arch Pharm (Weinheim). 2007 Aug;340(8):389-95.","parent_key":"BE0000530"}
{"ref-id":"A15420","pubmed-id":17205742,"citation":"Xie WJ, Feng YP, Cao SL, Zhao YF: [Study of the interaction between methotrexate and bovine serum albumin by spectrometry]. Guang Pu Xue Yu Guang Pu Fen Xi. 2006 Oct;26(10):1876-9.","parent_key":"BE0000530"}
{"ref-id":"A179053","pubmed-id":9212783,"citation":"Nerli B, Romanini D, Pico G: Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin. Chem Biol Interact. 1997 May 2;104(2-3):179-202.","parent_key":"BE0000530"}
{"ref-id":"A180190","pubmed-id":19043274,"citation":"Miida H, Noritake Y, Shimoda H, Honda K, Matsuoka T, Sakurai K, Shirai M, Manabe S, Takasaki W, Ueno K: Decrease in protein binding and its effect on toxicokinetics (TK)/toxicodynamics (TD) of diclofenac and propranolol in pregnant rats. J Toxicol Sci. 2008 Dec;33(5):525-36.","parent_key":"BE0000925"}
{"ref-id":"A180190","pubmed-id":19043274,"citation":"Miida H, Noritake Y, Shimoda H, Honda K, Matsuoka T, Sakurai K, Shirai M, Manabe S, Takasaki W, Ueno K: Decrease in protein binding and its effect on toxicokinetics (TK)/toxicodynamics (TD) of diclofenac and propranolol in pregnant rats. J Toxicol Sci. 2008 Dec;33(5):525-36.","parent_key":"BE0000530"}
{"ref-id":"A180559","pubmed-id":10215710,"citation":"Khan ZP, Ferguson CN, Jones RM: alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999 Feb;54(2):146-65. doi: 10.1046/j.1365-2044.1999.00659.x.","parent_key":"BE0000530"}
{"ref-id":"A11910","pubmed-id":2545072,"citation":"Brodersen R, Honore B: Drug binding properties of neonatal albumin. Acta Paediatr Scand. 1989 May;78(3):342-6.","parent_key":"BE0000530"}
{"ref-id":"A11911","pubmed-id":5421619,"citation":"Agren A, Elofsson R, Meresaar U, Nilsson SO: Complex formation between macromolecules and drugs. 3. A study of the influence of ionic strength and pH. Binding between Aptin, nortriptyline, sulfamethizole or tripelenamine and serum albumin, poly-arginine, poly-lysine, poly-ornithine, protamine or dextran sulfate. Acta Pharm Suec. 1970 Apr;7(2):105-12.","parent_key":"BE0000530"}
{"ref-id":"A11912","pubmed-id":7380930,"citation":"Nakano NI, Shimamori Y, Yamaguchi S: Mutual displacement interactions in the binding of two drugs to human serum albumin by frontal affinity chromatography. J Chromatogr. 1980 Feb 1;188(2):347-56.","parent_key":"BE0000530"}
{"ref-id":"A11913","pubmed-id":8099962,"citation":"Angelakou A, Valsami G, Koupparis M, Macheras P: Use of 1-anilino-8-napthalenesulphonate as an ion probe for the potentiometric study of the binding of sulphonamides to bovine serum albumin and plasma. J Pharm Pharmacol. 1993 May;45(5):434-8.","parent_key":"BE0000530"}
{"ref-id":"A179155","pubmed-id":25845252,"citation":"Trbojevic-Stankovic J, Aleksic M, Odovic J: Estimation of angiotensin-converting enzyme inhibitors protein binding degree using chromatographic hydrophobicity data. Srp Arh Celok Lek. 2015 Jan-Feb;143(1-2):50-5.","parent_key":"BE0000530"}
{"ref-id":"A15410","pubmed-id":14727845,"citation":"Yamasaki K, Rahman MH, Tsutsumi Y, Maruyama T, Ahmed S, Kragh-Hansen U, Otagiri M: Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. AAPS PharmSciTech. 2000 May 14;1(2):E12.","parent_key":"BE0000530"}
{"ref-id":"A178633","pubmed-id":9314611,"citation":"Davies NM, Anderson KE: Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet. 1997 Sep;33(3):184-213. doi: 10.2165/00003088-199733030-00003.","parent_key":"BE0000530"}
{"ref-id":"A192537","citation":"Keswani N, Choudhary S, Kishore N: Quantitative aspects of recognition of the antibiotic drug oxytetracycline by bovine serum albumin: Calorimetric and spectroscopic studies The Journal of Chemical Thermodynamics. 2013 Mar;58:196-205.","parent_key":"BE0000530"}
{"ref-id":"A181886","pubmed-id":16944456,"citation":"Martinez-Gomez MA, Sagrado S, Villanueva-Camanas RM, Medina-Hernandez MJ: Characterization of basic drug-human serum protein interactions by capillary electrophoresis. Electrophoresis. 2006 Sep;27(17):3410-9. doi: 10.1002/elps.200600102.","parent_key":"BE0000530"}
{"ref-id":"A181886","pubmed-id":16944456,"citation":"Martinez-Gomez MA, Sagrado S, Villanueva-Camanas RM, Medina-Hernandez MJ: Characterization of basic drug-human serum protein interactions by capillary electrophoresis. Electrophoresis. 2006 Sep;27(17):3410-9. doi: 10.1002/elps.200600102.","parent_key":"BE0004879"}
{"ref-id":"A186068","pubmed-id":6457935,"citation":"Akpoviroro JO, Mangalam M, Jenkins N, Fotherby K: Binding of the contraceptive steroids medroxyprogesterone acetate and ethynyloestradiol in blood of various species. J Steroid Biochem. 1981 May;14(5):493-8. doi: 10.1016/0022-4731(81)90362-9.","parent_key":"BE0000530"}
{"ref-id":"A15459","pubmed-id":12705172,"citation":"Russeva VN, Zhivkova ZD: Molecular basis of sulindac competition with specific markers for the major binding sites on human serum albumin. Arzneimittelforschung. 2003;53(3):174-81.","parent_key":"BE0000530"}
{"ref-id":"A15460","pubmed-id":671241,"citation":"Shams-Eldeen MA, Vallner JJ, Needham TE: Interaction of sulindac and metabolite with human serum albumin. J Pharm Sci. 1978 Aug;67(8):1077-80.","parent_key":"BE0000530"}
{"ref-id":"A15461","pubmed-id":12608015,"citation":"Zhivkova ZD, Russeva VN: Thermodynamic characterization of the binding process of sulindac to human serum albumin. Arzneimittelforschung. 2003;53(1):53-6.","parent_key":"BE0000530"}
{"ref-id":"A191667","pubmed-id":3768249,"citation":"Ofori-Adjei D, Ericsson O, Lindstrom B, Sjoqvist F: Protein binding of chloroquine enantiomers and desethylchloroquine. Br J Clin Pharmacol. 1986 Sep;22(3):356-8. doi: 10.1111/j.1365-2125.1986.tb02900.x.","parent_key":"BE0000530"}
{"ref-id":"A191667","pubmed-id":3768249,"citation":"Ofori-Adjei D, Ericsson O, Lindstrom B, Sjoqvist F: Protein binding of chloroquine enantiomers and desethylchloroquine. Br J Clin Pharmacol. 1986 Sep;22(3):356-8. doi: 10.1111/j.1365-2125.1986.tb02900.x.","parent_key":"BE0004879"}
{"ref-id":"A184223","pubmed-id":13700365,"citation":"FLORINI JR, BUYSKE DA: Plasma protein binding of triamcinolone-H3 and hydrocortisone-4-C14. J Biol Chem. 1961 Jan;236:247-51.","parent_key":"BE0000530"}
{"ref-id":"A12103","pubmed-id":3521955,"citation":"Pardridge WM: Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab. 1986 May;15(2):259-78.","parent_key":"BE0000530"}
{"ref-id":"A187015","pubmed-id":2732295,"citation":"Guechot J, Loric S, Vaubourdolle M, Chretien Y, Giboudeau J, Poupon R: Effect of protein binding on testosterone extraction by human cirrhotic liver: evidence for a dissociation-limited uptake. J Clin Endocrinol Metab. 1989 Jul;69(1):200-3. doi: 10.1210/jcem-69-1-200.","parent_key":"BE0000530"}
{"ref-id":"A17951","pubmed-id":3593903,"citation":"Ferry JJ, Wagner JG: The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma. Biopharm Drug Dispos. 1987 May-Jun;8(3):261-72.","parent_key":"BE0000530"}
{"ref-id":"A187436","pubmed-id":15634032,"citation":"Czock D, Keller F, Rasche FM, Haussler U: Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61-98. doi: 10.2165/00003088-200544010-00003.","parent_key":"BE0000530"}
{"ref-id":"A15472","pubmed-id":11259571,"citation":"Tan E, Lu T, Pang KS: Futile cycling of estrone sulfate and estrone in the recirculating perfused rat liver preparation. J Pharmacol Exp Ther. 2001 Apr;297(1):423-36.","parent_key":"BE0000530"}
{"ref-id":"A182207","pubmed-id":2702659,"citation":"Lien EA, Solheim E, Lea OA, Lundgren S, Kvinnsland S, Ueland PM: Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res. 1989 Apr 15;49(8):2175-83.","parent_key":"BE0000530"}
{"ref-id":"A19924","pubmed-id":15525694,"citation":"Peeples ES, Schopfer LM, Duysen EG, Spaulding R, Voelker T, Thompson CM, Lockridge O: Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol Sci. 2005 Feb;83(2):303-12. Epub 2004 Nov 3.","parent_key":"BE0000530"}
{"ref-id":"A19925","pubmed-id":17188226,"citation":"Li B, Schopfer LM, Hinrichs SH, Masson P, Lockridge O: Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay for organophosphorus toxicants bound to human albumin at Tyr411. Anal Biochem. 2007 Feb 15;361(2):263-72. Epub 2006 Dec 4.","parent_key":"BE0000530"}
{"ref-id":"A1033","pubmed-id":16029066,"citation":"Sica DA, Gehr TW, Ghosh S: Clinical pharmacokinetics of losartan. Clin Pharmacokinet. 2005;44(8):797-814.","parent_key":"BE0000530"}
{"ref-id":"A14238","pubmed-id":8695640,"citation":"Yamasaki K, Maruyama T, Kragh-Hansen U, Otagiri M: Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim Biophys Acta. 1996 Jul 18;1295(2):147-57.","parent_key":"BE0000530"}
{"ref-id":"A15493","pubmed-id":20537832,"citation":"Joseph KS, Hage DS: The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. J Pharm Biomed Anal. 2010 Nov 2;53(3):811-8. doi: 10.1016/j.jpba.2010.04.035. Epub 2010 May 6.","parent_key":"BE0000530"}
{"ref-id":"A15494","pubmed-id":18721856,"citation":"Wybranowski T, Cyrankiewicz M, Ziomkowska B, Kruszewski S: The HSA affinity of warfarin and flurbiprofen determined by fluorescence anisotropy measurements of camptothecin. Biosystems. 2008 Dec;94(3):258-62. doi: 10.1016/j.biosystems.2008.05.034. Epub 2008 Jul 31.","parent_key":"BE0000530"}
{"ref-id":"A12212","pubmed-id":16290938,"citation":"Hazai E, Visy J, Fitos I, Bikadi Z, Simonyi M: Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants. Bioorg Med Chem. 2006 Mar 15;14(6):1959-65. Epub 2005 Nov 15.","parent_key":"BE0000925"}
{"ref-id":"A187147","pubmed-id":28435101,"citation":"Abboud R, Akil M, Charcosset C, Greige-Gerges H: Interaction of glucocorticoids and progesterone derivatives with human serum albumin. Chem Phys Lipids. 2017 Oct;207(Pt B):271-278. doi: 10.1016/j.chemphyslip.2017.04.007. Epub 2017 Apr 21.","parent_key":"BE0000530"}
{"ref-id":"A15492","pubmed-id":2792351,"citation":"Lebedev AA, Samokrutova OV: [Study of the binding of diuretics by serum proteins according to changes in tryptophan fluorescence]. Farmakol Toksikol. 1989 May-Jun;52(3):40-3.","parent_key":"BE0000530"}
{"ref-id":"A12048","pubmed-id":10737910,"citation":"Matsushima H, Watanabe T, Higuchi S: Effect of alpha(1)-acid glycoprotein on the pharmacokinetics of tamsulosin in rats treated with turpentine oil. J Pharm Sci. 2000 Apr;89(4):490-8.","parent_key":"BE0000925"}
{"ref-id":"A12049","pubmed-id":17666829,"citation":"Hanada K, Tochikura N, Ogata H: Selective binding of tamsulosin to genetic variants of human alpha1-acid glycoprotein. Biol Pharm Bull. 2007 Aug;30(8):1593-5.","parent_key":"BE0000925"}
{"ref-id":"A12050","pubmed-id":8973992,"citation":"Koiso K, Akaza H, Kikuchi K, Aoyagi K, Ohba S, Miyazaki M, Ito M, Sueyoshi T, Matsushima H, Kamimura H, Watanabe T, Higuchi S: Pharmacokinetics of tamsulosin hydrochloride in patients with renal impairment: effects of alpha 1-acid glycoprotein. J Clin Pharmacol. 1996 Nov;36(11):1029-38.","parent_key":"BE0000925"}
{"ref-id":"A15772","pubmed-id":2867185,"citation":"Aarons L, Khan AZ, Grennan DM, Alam-Siddiqi M: The binding of flurbiprofen to plasma proteins. J Pharm Pharmacol. 1985 Sep;37(9):644-6.","parent_key":"BE0000530"}
{"ref-id":"A15773","pubmed-id":16867708,"citation":"Takla PG, Schulman SG, Perrin JH: Measurement of flurbiprofen-human serum albumin interaction by fluorimetry. J Pharm Biomed Anal. 1985;3(1):41-50.","parent_key":"BE0000530"}
{"ref-id":"A177817","pubmed-id":20225277,"citation":"Fanali G, Rampoldi V, di Masi A, Bolli A, Lopiano L, Ascenzi P, Fasano M: Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated. IUBMB Life. 2010 May;62(5):371-6. doi: 10.1002/iub.317.","parent_key":"BE0000530"}
{"ref-id":"A179629","pubmed-id":27767393,"citation":"Ariga GG, Naik PN, Nandibewoor ST, Chimatadar SA: Quenching of fluorescence by meclizine, a probe study for structural and conformational changes in human serum albumin. J Biomol Struct Dyn. 2017 Nov;35(14):3161-3175. doi: 10.1080/07391102.2016.1245159. Epub 2016 Nov 10.","parent_key":"BE0000530"}
{"ref-id":"A12073","pubmed-id":16118549,"citation":"Port M, Corot C, Violas X, Robert P, Raynal I, Gagneur G: How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Invest Radiol. 2005 Sep;40(9):565-73.","parent_key":"BE0000530"}
{"ref-id":"A12074","pubmed-id":9055236,"citation":"Wendland MF, Saeed M, Lauerma K, Derugin N, Mintorovitch J, Cavagna FM, Higgins CB: Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med. 1997 Mar;37(3):448-56.","parent_key":"BE0000530"}
{"ref-id":"A12075","pubmed-id":9406019,"citation":"Cavagna FM, Maggioni F, Castelli PM, Dapra M, Imperatori LG, Lorusso V, Jenkins BG: Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol. 1997 Dec;32(12):780-96.","parent_key":"BE0000530"}
{"ref-id":"A9","pubmed-id":11752352,"citation":"Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.","parent_key":"BE0000530"}
{"ref-id":"A20069","pubmed-id":17944539,"citation":"Li F, Chordia MD, Woodling KA, Macdonald TL: Irreversible alkylation of human serum albumin by zileuton metabolite 2-acetylbenzothiophene-S-oxide: a potential model for hepatotoxicity. Chem Res Toxicol. 2007 Dec;20(12):1854-61. Epub 2007 Oct 19.","parent_key":"BE0000530"}
{"ref-id":"A15462","pubmed-id":8777148,"citation":"Mignot I, Presle N, Lapicque F, Monot C, Dropsy R, Netter P: Albumin binding sites for etodolac enantiomers. Chirality. 1996;8(3):271-80.","parent_key":"BE0000530"}
{"ref-id":"A15463","pubmed-id":1389961,"citation":"Muller N, Lapicque F, Monot C, Payan E, Dropsy R, Netter P: Stereoselective binding of etodolac to human serum albumin. Chirality. 1992;4(4):240-6.","parent_key":"BE0000530"}
{"ref-id":"A15464","pubmed-id":1362954,"citation":"Smith PC, Song WQ, Rodriguez RJ: Covalent binding of etodolac acyl glucuronide to albumin in vitro. Drug Metab Dispos. 1992 Nov-Dec;20(6):962-5.","parent_key":"BE0000530"}
{"ref-id":"A19987","pubmed-id":16569428,"citation":"Maiti TK, Ghosh KS, Debnath J, Dasgupta S: Binding of all-trans retinoic acid to human serum albumin: fluorescence, FT-IR and circular dichroism studies. Int J Biol Macromol. 2006 May 30;38(3-5):197-202. Epub 2006 Mar 6.","parent_key":"BE0000530"}
{"ref-id":"A19988","pubmed-id":17184834,"citation":"N'soukpoe-Kossi CN, Sedaghat-Herati R, Ragi C, Hotchandani S, Tajmir-Riahi HA: Retinol and retinoic acid bind human serum albumin: stability and structural features. Int J Biol Macromol. 2007 Apr 10;40(5):484-90. Epub 2006 Nov 24.","parent_key":"BE0000530"}
{"ref-id":"A192615","pubmed-id":4729699,"citation":"Agren A, Back T: Complex formation between macromolecules and drugs. 8. Binding of saccharine, N-methyl saccharine, and the diuretic drugs hydroflumethiazide and bendroflumethiazide to human serum albumin. Acta Pharm Suec. 1973 Jun;10(3):223-8.","parent_key":"BE0000530"}
{"ref-id":"A12102","pubmed-id":8530713,"citation":"O'Connell MB: Pharmacokinetic and pharmacologic variation between different estrogen products. J Clin Pharmacol. 1995 Sep;35(9S):18S-24S. doi: 10.1002/j.1552-4604.1995.tb04143.x.","parent_key":"BE0000530"}
{"ref-id":"A180895","pubmed-id":29113080,"citation":"Abdelhameed AS, Bakheit AH, Almutairi FM, AlRabiah H, Kadi AA: Biophysical and In Silico Studies of the Interaction between the Anti-Viral Agents Acyclovir and Penciclovir, and Human Serum Albumin. Molecules. 2017 Nov 5;22(11). pii: molecules22111906. doi: 10.3390/molecules22111906.","parent_key":"BE0000530"}
{"ref-id":"A1991","pubmed-id":10592235,"citation":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.","parent_key":"BE0000530"}
{"ref-id":"A178999","pubmed-id":18259051,"citation":"Lejon S, Cramer JF, Nordberg P: Structural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA module. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Feb 1;64(Pt 2):64-9. doi: 10.1107/S174430910706770X. Epub 2008 Jan 18.","parent_key":"BE0000530"}
{"ref-id":"A179110","pubmed-id":9113437,"citation":"Davies NM, Anderson KE: Clinical pharmacokinetics of naproxen. Clin Pharmacokinet. 1997 Apr;32(4):268-93. doi: 10.2165/00003088-199732040-00002.","parent_key":"BE0000530"}
{"ref-id":"A15476","pubmed-id":2071261,"citation":"Belpaire FM, Bogaert MG: Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum. Int J Clin Pharmacol Ther Toxicol. 1991 Mar;29(3):96-102.","parent_key":"BE0000925"}
{"ref-id":"A15477","pubmed-id":3146505,"citation":"Kumar K, Crankshaw DP, Morgan DJ, Beemer GH: The effect of cardiopulmonary bypass on plasma protein binding of alfentanil. Eur J Clin Pharmacol. 1988;35(1):47-52.","parent_key":"BE0000925"}
{"ref-id":"A15476","pubmed-id":2071261,"citation":"Belpaire FM, Bogaert MG: Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum. Int J Clin Pharmacol Ther Toxicol. 1991 Mar;29(3):96-102.","parent_key":"BE0000530"}
{"ref-id":"A15477","pubmed-id":3146505,"citation":"Kumar K, Crankshaw DP, Morgan DJ, Beemer GH: The effect of cardiopulmonary bypass on plasma protein binding of alfentanil. Eur J Clin Pharmacol. 1988;35(1):47-52.","parent_key":"BE0000530"}
{"ref-id":"A204041","pubmed-id":3395370,"citation":"Urien S, Riant P, Renouard A, Coulomb B, Rocher I, Tillement JP: Binding of indapamide to serum proteins and erythrocytes. Biochem Pharmacol. 1988 Aug 1;37(15):2963-6. doi: 10.1016/0006-2952(88)90282-1.","parent_key":"BE0004879"}
{"ref-id":"A204041","pubmed-id":3395370,"citation":"Urien S, Riant P, Renouard A, Coulomb B, Rocher I, Tillement JP: Binding of indapamide to serum proteins and erythrocytes. Biochem Pharmacol. 1988 Aug 1;37(15):2963-6. doi: 10.1016/0006-2952(88)90282-1.","parent_key":"BE0000530"}
{"ref-id":"A179536","pubmed-id":25314012,"citation":"Bista SR, Haywood A, Hardy J, Lobb M, Tapuni A, Norris R: Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and alpha-1 acid glycoprotein. Xenobiotica. 2015 Mar;45(3):207-12. doi: 10.3109/00498254.2014.971093. Epub 2014 Oct 14.","parent_key":"BE0000530"}
{"ref-id":"A179536","pubmed-id":25314012,"citation":"Bista SR, Haywood A, Hardy J, Lobb M, Tapuni A, Norris R: Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and alpha-1 acid glycoprotein. Xenobiotica. 2015 Mar;45(3):207-12. doi: 10.3109/00498254.2014.971093. Epub 2014 Oct 14.","parent_key":"BE0004879"}
{"ref-id":"A190189","pubmed-id":30774225,"citation":"Bekker A, Kloepping C, Collingwood S: Meloxicam in the management of post-operative pain: Narrative review. J Anaesthesiol Clin Pharmacol. 2018 Oct-Dec;34(4):450-457. doi: 10.4103/joacp.JOACP_133_18.","parent_key":"BE0000530"}
{"ref-id":"A190234","pubmed-id":20089378,"citation":"Trynda-Lemiesz L, Wiglusz K: Interactions of human serum albumin with meloxicam: characterization of binding site. J Pharm Biomed Anal. 2010 Jun 5;52(2):300-4. doi: 10.1016/j.jpba.2009.12.025. Epub 2010 Jan 4.","parent_key":"BE0000530"}
{"ref-id":"A12111","pubmed-id":16085141,"citation":"Chang-Ying Y, An-Xin H, Yi L, Hui T, Song-Sheng Q: Some properties of the interaction between 2,2'-diselenadibenzoic acid and serum albumins. J Pharm Biomed Anal. 2005 Sep 1;39(1-2):263-7.","parent_key":"BE0000530"}
{"ref-id":"A12112","pubmed-id":16256532,"citation":"Choi EJ, Foster MD: Surfactant displacement of human serum albumin adsorbed on loosely packed self-assembled monolayers: cetyltrimethylammonium bromide versus sodium dodecyl sulfate. J Colloid Interface Sci. 2003 May 15;261(2):273-82.","parent_key":"BE0000530"}
{"ref-id":"A12113","pubmed-id":16256620,"citation":"Santos SF, Zanette D, Fischer H, Itri R: A systematic study of bovine serum albumin (BSA) and sodium dodecyl sulfate (SDS) interactions by surface tension and small angle X-ray scattering. J Colloid Interface Sci. 2003 Jun 15;262(2):400-8.","parent_key":"BE0000530"}
{"ref-id":"A12114","pubmed-id":16379295,"citation":"Cao WG, Jiao QC, Liu Q: [Spatial orientation interaction mechanism of three component complex of protein--BSA/SDS/Azur a system]. Guang Pu Xue Yu Guang Pu Fen Xi. 2005 Sep;25(9):1478-81.","parent_key":"BE0000530"}
{"ref-id":"A12115","pubmed-id":16457837,"citation":"Schweitzer B, Felippe AC, Dal Bo A, Minatti E, Zanette D, Lopes A: Sodium dodecyl sulfate promoting a cooperative association process of sodium cholate with bovine serum albumin. J Colloid Interface Sci. 2006 Jun 1;298(1):457-66. Epub 2006 Feb 2.","parent_key":"BE0000530"}
{"ref-id":"A15478","pubmed-id":17311911,"citation":"Bright DP, Adham SD, Lemaire LC, Benavides R, Gruss M, Taylor GW, Smith EH, Franks NP: Identification of anesthetic binding sites on human serum albumin using a novel etomidate photolabel. J Biol Chem. 2007 Apr 20;282(16):12038-47. Epub 2007 Feb 20.","parent_key":"BE0000530"}
{"ref-id":"A15481","pubmed-id":16032968,"citation":"Schywalsky M, Ihmsen H, Knoll R, Schwilden H: Binding of propofol to human serum albumin. Arzneimittelforschung. 2005;55(6):303-6.","parent_key":"BE0000530"}
{"ref-id":"A203354","pubmed-id":21671987,"citation":"Chin PK, Jensen BP, Larsen HS, Begg EJ: Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. Br J Clin Pharmacol. 2011 Dec;72(6):985-9. doi: 10.1111/j.1365-2125.2011.04036.x.","parent_key":"BE0000530"}
{"ref-id":"A189354","pubmed-id":30391401,"citation":"Volpp M, Holzgrabe U: Determination of plasma protein binding for sympathomimetic drugs by means of ultrafiltration. Eur J Pharm Sci. 2019 Jan 15;127:175-184. doi: 10.1016/j.ejps.2018.10.027. Epub 2018 Oct 31.","parent_key":"BE0000530"}
{"ref-id":"A188165","pubmed-id":8557388,"citation":"Schafer-Korting M, Korting HC, Rittler W, Obermuller W: Influence of serum protein binding on the in vitro activity of anti-fungal agents. Infection. 1995 Sep-Oct;23(5):292-7. doi: 10.1007/bf01716289.","parent_key":"BE0000530"}
{"ref-id":"A5538","pubmed-id":1287164,"citation":"Ryder NS, Frank I: Interaction of terbinafine with human serum and serum proteins. J Med Vet Mycol. 1992;30(6):451-60.","parent_key":"BE0000530"}
{"ref-id":"A5538","pubmed-id":1287164,"citation":"Ryder NS, Frank I: Interaction of terbinafine with human serum and serum proteins. J Med Vet Mycol. 1992;30(6):451-60.","parent_key":"BE0004879"}
{"ref-id":"A187394","pubmed-id":378499,"citation":"Pickup ME: Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet. 1979 Mar-Apr;4(2):111-28. doi: 10.2165/00003088-197904020-00004.","parent_key":"BE0000530"}
{"ref-id":"A15465","pubmed-id":17132209,"citation":"Davilas A, Koupparis M, Macheras P, Valsami G: In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique. J Pharm Pharmacol. 2006 Nov;58(11):1467-74.","parent_key":"BE0000530"}
{"ref-id":"A10900","pubmed-id":11673972,"citation":"Mao H, Hajduk PJ, Craig R, Bell R, Borre T, Fesik SW: Rational design of diflunisal analogues with reduced affinity for human serum albumin. J Am Chem Soc. 2001 Oct 31;123(43):10429-35.","parent_key":"BE0000530"}
{"ref-id":"A12216","pubmed-id":2751413,"citation":"Rehse K, Fiedler B: [Determination of the protein binding of drugs by continuous ultrafiltration. 9. Comparison of the binding of nonsteroid antirheumatics to human serum albumin and their interaction with phenprocoumon]. Arch Pharm (Weinheim). 1989 Apr;322(4):241-3.","parent_key":"BE0000530"}
{"ref-id":"A15466","pubmed-id":7371361,"citation":"Verbeeck RK, De Schepper PJ: Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding. Clin Pharmacol Ther. 1980 May;27(5):628-35.","parent_key":"BE0000530"}
{"ref-id":"A192549","pubmed-id":11566558,"citation":"Moser J, Hye A, Lovell WW, Earl LK, Castell JV, Miranda MA: Mechanisms of drug photobinding to proteins: photobinding of suprofen to human serum albumin. Toxicol In Vitro. 2001 Aug-Oct;15(4-5):333-7. doi: 10.1016/s0887-2333(01)00033-9.","parent_key":"BE0000530"}
{"ref-id":"A192552","pubmed-id":6714853,"citation":"Hasegawa J, Nakayama T, Nozaki M, Fujimura H: [Interaction of suprofen and serum albumin]. Nihon Yakurigaku Zasshi. 1984 Jan;83(1):85-91.","parent_key":"BE0000530"}
{"ref-id":"A192555","pubmed-id":1400761,"citation":"Noctor TA, Wainer IW, Hage DS: Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. J Chromatogr. 1992 Jun 10;577(2):305-15. doi: 10.1016/0378-4347(92)80252-l.","parent_key":"BE0000530"}
{"ref-id":"A190435","pubmed-id":4269593,"citation":"Hjeljord LG, Rolla G, Bonesvoll P: Chlorhexidine-protein interactions. J Periodontal Res Suppl. 1973;12:11-6. doi: 10.1111/j.1600-0765.1973.tb02158.x.","parent_key":"BE0000530"}
{"ref-id":"A185003","pubmed-id":27418394,"citation":"Shi JH, Pan DQ, Jiang M, Liu TT, Wang Q: In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods. J Biomol Struct Dyn. 2017 Aug;35(10):2211-2223. doi: 10.1080/07391102.2016.1213663. Epub 2016 Aug 7.","parent_key":"BE0000530"}
{"ref-id":"A15490","pubmed-id":9863950,"citation":"Bertucci C, Nanni B, Raffaelli A, Salvadori P: Chemical modification of human albumin at cys34 by ethacrynic acid: structural characterisation and binding properties. J Pharm Biomed Anal. 1998 Oct;18(1-2):127-36.","parent_key":"BE0000530"}
{"ref-id":"A15491","pubmed-id":3714803,"citation":"Fehske KJ, Muller WE: High-affinity binding of ethacrynic acid is mediated by the two most important drug binding sites of human serum albumin. Pharmacology. 1986;32(4):208-13.","parent_key":"BE0000530"}
{"ref-id":"A192411","pubmed-id":3247314,"citation":"Edwards DJ, Bowles SK: Protein binding of cocaine in human serum. Pharm Res. 1988 Jul;5(7):440-2. doi: 10.1023/a:1015992502509.","parent_key":"BE0004879"}
{"ref-id":"A192414","pubmed-id":7473145,"citation":"Parker RB, Williams CL, Laizure SC, Lima JJ: Factors affecting serum protein binding of cocaine in humans. J Pharmacol Exp Ther. 1995 Nov;275(2):605-10.","parent_key":"BE0004879"}
{"ref-id":"A12174","pubmed-id":11814462,"citation":"Li JH, Xu JQ, Cao XM, Ni L, Li Y, Zhuang YY, Gong JB: Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine. Clin Chim Acta. 2002 Mar;317(1-2):85-92.","parent_key":"BE0000925"}
{"ref-id":"A12175","pubmed-id":9620113,"citation":"McCollam PL, Crouch MA, Arnaud P: Caucasian versus African-American differences in orosomucoid: potential implications for therapy. Pharmacotherapy. 1998 May-Jun;18(3):620-6.","parent_key":"BE0000925"}
{"ref-id":"A184919","pubmed-id":30717459,"citation":"Baig MH, Rahman S, Rabbani G, Imran M, Ahmad K, Choi I: Multi-Spectroscopic Characterization of Human Serum Albumin Binding with Cyclobenzaprine Hydrochloride: Insights from Biophysical and In Silico Approaches. Int J Mol Sci. 2019 Feb 3;20(3). pii: ijms20030662. doi: 10.3390/ijms20030662.","parent_key":"BE0000530"}
{"ref-id":"A15597","pubmed-id":3368020,"citation":"Eap CB, Cuendet C, Baumann P: Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein. Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):220-4.","parent_key":"BE0000925"}
{"ref-id":"A15598","pubmed-id":7461027,"citation":"Lynn K, Braithwaite R, Dawling S, Rosser R: Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis. Eur J Clin Pharmacol. 1981 Jan;19(1):73-7.","parent_key":"BE0000925"}
{"ref-id":"A12196","pubmed-id":15768982,"citation":"Xiao HR, Sheng LQ, Shi CH, Xu XL, Xie YS, Liu QL: [Fluorescence study on the interaction of salicylic acid and bovine serum albumin]. Guang Pu Xue Yu Guang Pu Fen Xi. 2004 Jan;24(1):78-81.","parent_key":"BE0000530"}
{"ref-id":"A12197","pubmed-id":17320187,"citation":"Yin T, Wei W, Yang L, Liu K, Gao X: Kinetics parameter estimation for the binding process of salicylic acid to human serum albumin (HSA) with capacitive sensing technique. J Biochem Biophys Methods. 2007 Jun 10;70(4):587-93. Epub 2007 Jan 27.","parent_key":"BE0000530"}
{"ref-id":"A12198","pubmed-id":15819089,"citation":"Yu T, Tao Z: [Fluorescence study on the interaction of salicylic acid and human serum albumin]. Guang Pu Xue Yu Guang Pu Fen Xi. 1999 Jun;19(3):453-5.","parent_key":"BE0000530"}
{"ref-id":"A183737","pubmed-id":11825095,"citation":"Cazzola M, Testi R, Matera MG: Clinical pharmacokinetics of salmeterol. Clin Pharmacokinet. 2002;41(1):19-30. doi: 10.2165/00003088-200241010-00003.","parent_key":"BE0000530"}
{"ref-id":"A183737","pubmed-id":11825095,"citation":"Cazzola M, Testi R, Matera MG: Clinical pharmacokinetics of salmeterol. Clin Pharmacokinet. 2002;41(1):19-30. doi: 10.2165/00003088-200241010-00003.","parent_key":"BE0004879"}
{"ref-id":"A12213","pubmed-id":1205658,"citation":"Niedner R, von Oettingen U, Meyer F: [The reciprocal actions of phenprocoumon (Marcumar) with human serum albumin, erythrocytes and blood]. Int J Clin Pharmacol Biopharm. 1975 Dec;12(4):446-57.","parent_key":"BE0000530"}
{"ref-id":"A12214","pubmed-id":12543492,"citation":"Fitos I, Visy J, Simonyi M: Species-dependency in chiral-drug recognition of serum albumin studied by chromatographic methods. J Biochem Biophys Methods. 2002 Dec 31;54(1-3):71-84.","parent_key":"BE0000530"}
{"ref-id":"A12215","pubmed-id":1642965,"citation":"Fitos I, Simonyi M: Stereoselective effect of phenprocoumon enantiomers on the binding of benzodiazepines to human serum albumin. Chirality. 1992;4(1):21-3.","parent_key":"BE0000530"}
{"ref-id":"A12217","pubmed-id":4762907,"citation":"Niedner R, von Oettingen U, Meyer F: [Binding of phenprocoumarol (Marcumar) to human albumin]. Int J Clin Pharmacol. 1973 Oct;8(2):160-6.","parent_key":"BE0000530"}
{"ref-id":"A12211","pubmed-id":11002825,"citation":"Otagiri M, Maruyama T, Imai T, Imamura Y: Fluorescent investigations of binding of phenprocoumon to alpha 1-acid glycoprotein. J Pharm Sci. 1987 Aug;76(8):646-9.","parent_key":"BE0000925"}
{"ref-id":"A20243","pubmed-id":25489718,"citation":"Meng X, Maggs JL, Usui T, Whitaker P, French NS, Naisbitt DJ, Park BK: Auto-oxidation of Isoniazid Leads to Isonicotinic-Lysine Adducts on Human Serum Albumin. Chem Res Toxicol. 2015 Jan 20;28(1):51-8. doi: 10.1021/tx500285k. Epub 2014 Dec 9.","parent_key":"BE0000530"}
{"ref-id":"A19867","pubmed-id":12586319,"citation":"Hammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.","parent_key":"BE0000530"}
{"ref-id":"A191182","pubmed-id":2308344,"citation":"Kuhnz W, Pfeffer M, al-Yacoub G: Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum. J Steroid Biochem. 1990 Feb;35(2):313-8. doi: 10.1016/0022-4731(90)90290-9.","parent_key":"BE0000530"}
{"ref-id":"A179091","pubmed-id":20436884,"citation":"Layton A: The use of isotretinoin in acne. Dermatoendocrinol. 2009 May;1(3):162-9. doi: 10.4161/derm.1.3.9364.","parent_key":"BE0000530"}
{"ref-id":"A179094","pubmed-id":12164942,"citation":"Tsukada M, Schroder M, Seltmann H, Orfanos CE, Zouboulis CC: High albumin levels restrict the kinetics of 13-cis retinoic acid uptake and intracellular isomerization to all-trans retinoic acid and inhibit its anti-proliferative effect on SZ95 sebocytes. J Invest Dermatol. 2002 Jul;119(1):182-5. doi: 10.1046/j.1523-1747.2002.01816.x.","parent_key":"BE0000530"}
{"ref-id":"A189603","pubmed-id":25272656,"citation":"Sochacka J: Docking of thiopurine derivatives to human serum albumin and binding site analysis with Molegro Virtual Docker. Acta Pol Pharm. 2014 Mar-Apr;71(2):343-9.","parent_key":"BE0000530"}
{"ref-id":"A189633","pubmed-id":1799934,"citation":"Tanaka M, Asahi Y, Masuda S, Ota T: Binding position of azathioprine with bovine serum albumin determined by measuring nuclear magnetic resonance relaxation time. Chem Pharm Bull (Tokyo). 1991 Nov;39(11):2771-4. doi: 10.1248/cpb.39.2771.","parent_key":"BE0000530"}
{"ref-id":"A12250","pubmed-id":11666224,"citation":"Roberts JR, Xiao J, Schliesman B, Parsons DJ, Shaw CF 3rd: Kinetics and Mechanism of the Reaction between Serum Albumin and Auranofin (and Its Isopropyl Analogue) in Vitro. Inorg Chem. 1996 Jan 17;35(2):424-433.","parent_key":"BE0000530"}
{"ref-id":"A12251","pubmed-id":2403377,"citation":"Shaw CF 3rd, Isab AA, Coffer MT, Mirabelli CK: Gold(I) efflux from auranofin-treated red blood cells. Evidence for a glutathione-gold-albumin metabolite. Biochem Pharmacol. 1990 Sep 15;40(6):1227-34.","parent_key":"BE0000530"}
{"ref-id":"A12252","pubmed-id":3655788,"citation":"Coffer MT, Shaw CF 3rd, Hormann AL, Mirabelli CK, Crooke ST: Thiol competition for Et3PAuS-albumin: a nonenzymatic mechanism for Et3PO formation. J Inorg Biochem. 1987 Jul;30(3):177-87.","parent_key":"BE0000530"}
{"ref-id":"A12253","pubmed-id":7925457,"citation":"Christodoulou J, Sadler PJ, Tucker A: A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy. Eur J Biochem. 1994 Oct 1;225(1):363-8.","parent_key":"BE0000530"}
{"ref-id":"A19968","pubmed-id":16211657,"citation":"Kratz F, Mansour A, Soltau J, Warnecke A, Fichtner I, Unger C, Drevs J: Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen. Arch Pharm (Weinheim). 2005 Oct;338(10):462-72.","parent_key":"BE0000530"}
{"ref-id":"A19969","pubmed-id":17378599,"citation":"Schmid B, Chung DE, Warnecke A, Fichtner I, Kratz F: Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy. Bioconjug Chem. 2007 May-Jun;18(3):702-16. Epub 2007 Mar 23.","parent_key":"BE0000530"}
{"ref-id":"A185201","pubmed-id":30218717,"citation":"Balaei F, Ghobadi S: Hydrochlorothiazide binding to human serum albumin induces some compactness in the molecular structure of the protein: A multi-spectroscopic and computational study. J Pharm Biomed Anal. 2019 Jan 5;162:1-8. doi: 10.1016/j.jpba.2018.09.009. Epub 2018 Sep 5.","parent_key":"BE0000530"}
{"ref-id":"A190546","pubmed-id":17912633,"citation":"Bhatnagar AS: The discovery and mechanism of action of letrozole. Breast Cancer Res Treat. 2007;105 Suppl 1:7-17. doi: 10.1007/s10549-007-9696-3. Epub 2007 Oct 3.","parent_key":"BE0000530"}
{"ref-id":"A15467","pubmed-id":11400191,"citation":"Bertucci C: Enantioselective inhibition of the binding of rac-profens to human serum albumin induced by lithocholate. Chirality. 2001 Jul;13(7):372-8.","parent_key":"BE0000530"}
{"ref-id":"A15468","pubmed-id":11022905,"citation":"Lagrange F, Penhourcq F, Matoga M, Bannwarth B: Binding of ketoprofen enantiomers in various human albumin preparations. J Pharm Biomed Anal. 2000 Oct;23(5):793-802.","parent_key":"BE0000530"}
{"ref-id":"A15469","pubmed-id":12725696,"citation":"Li F, Zhou D, Guo X: Study on the protein binding of ketoprofen using capillary electrophoresis frontal analysis compared with liquid chromatography frontal analysis. J Chromatogr Sci. 2003 Mar;41(3):137-41.","parent_key":"BE0000530"}
{"ref-id":"A15470","pubmed-id":15807110,"citation":"Zhou D, Li F: [Study of protein binding in ketoprofen using liquid chromatography frontal analysis in comparison with capillary electrophoresis frontal analysis]. Se Pu. 2004 Nov;22(6):601-4.","parent_key":"BE0000530"}
{"ref-id":"A17549","pubmed-id":4153105,"citation":"Crooks MJ, Brown KF: The binding of sulphonylureas to serum albumin. J Pharm Pharmacol. 1974 May;26(5):304-11.","parent_key":"BE0000530"}
{"ref-id":"A17550","pubmed-id":4208196,"citation":"Hsu PL, Ma JK, Luzzi LA: Interactions of sulfonylureas with plasma proteins. J Pharm Sci. 1974 Apr;63(4):570-3.","parent_key":"BE0000530"}
{"ref-id":"A17551","pubmed-id":820348,"citation":"Brown KF, Crooks MJ: Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs. Biochem Pharmacol. 1976 May 15;25(10):1175-8.","parent_key":"BE0000530"}
{"ref-id":"A181805","pubmed-id":3280211,"citation":"Daneshmend TK, Warnock DW: Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet. 1988 Jan;14(1):13-34. doi: 10.2165/00003088-198814010-00002.","parent_key":"BE0000530"}
{"ref-id":"A15498","pubmed-id":3780693,"citation":"Dundee JW, Halliday NJ, McMurray TJ: Aspirin and probenecid pretreatment influences the potency of thiopentone and the onset of action of midazolam. Eur J Anaesthesiol. 1986 May;3(3):247-51.","parent_key":"BE0000530"}
{"ref-id":"A15500","pubmed-id":3977951,"citation":"Gewirtz DA, Holt SA: Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro. Biochem Pharmacol. 1985 Mar 15;34(6):747-54.","parent_key":"BE0000530"}
{"ref-id":"A15501","pubmed-id":2043725,"citation":"Hansen-Moller J, Schmit U: Rapid high-performance liquid chromatographic assay for the simultaneous determination of probenecid and its glucuronide in urine. Irreversible binding of probenecid to serum albumin. J Pharm Biomed Anal. 1991;9(1):65-73.","parent_key":"BE0000530"}
{"ref-id":"A185936","pubmed-id":3318449,"citation":"Chapman MJ: Pharmacology of fenofibrate. Am J Med. 1987 Nov 27;83(5B):21-5. doi: 10.1016/0002-9343(87)90867-9.","parent_key":"BE0000530"}
{"ref-id":"A15502","pubmed-id":15068289,"citation":"Guo M, Zou JW, Yi PG, Shang ZC, Hu GX, Yu QS: Binding interaction of gatifloxacin with bovine serum albumin. Anal Sci. 2004 Mar;20(3):465-70.","parent_key":"BE0000530"}
{"ref-id":"A15503","pubmed-id":16165044,"citation":"Tan F, Guo M, Yu Q: Studies on interaction between gatifloxacin and human serum albumin as well as effect of copper(II) on the reaction. Spectrochim Acta A Mol Biomol Spectrosc. 2005 Oct;61(13-14):3006-12. Epub 2004 Dec 19.","parent_key":"BE0000530"}
{"ref-id":"A15411","pubmed-id":20117876,"citation":"Galantini L, Leggio C, Konarev PV, Pavel NV: Human serum albumin binding ibuprofen: a 3D description of the unfolding pathway in urea. Biophys Chem. 2010 Apr;147(3):111-22. doi: 10.1016/j.bpc.2010.01.002. Epub 2010 Jan 18.","parent_key":"BE0000530"}
{"ref-id":"A192729","pubmed-id":5776014,"citation":"Joos RW, Hall WH: Determination of binding constants of serum albumin for penicillin. J Pharmacol Exp Ther. 1969 Mar;166(1):113-8.","parent_key":"BE0000530"}
{"ref-id":"A15623","pubmed-id":20359840,"citation":"Pistolozzi M, Franchini C, Corbo F, Muraglia M, De Giorgi M, Felix G, Bertucci C: Tocainide analogues binding to human serum albumin: a HPLAC and circular dichroism study. J Pharm Biomed Anal. 2010 Oct 10;53(2):179-85. doi: 10.1016/j.jpba.2010.03.005. Epub 2010 Mar 7.","parent_key":"BE0000530"}
{"ref-id":"A190633","pubmed-id":25088930,"citation":"Garzon D, Ariza A, Regazzoni L, Clerici R, Altomare A, Sirtori FR, Carini M, Torres MJ, Perez-Sala D, Aldini G: Mass spectrometric strategies for the identification and characterization of human serum albumin covalently adducted by amoxicillin: ex vivo studies. Chem Res Toxicol. 2014 Sep 15;27(9):1566-74. doi: 10.1021/tx500210e. Epub 2014 Aug 13.","parent_key":"BE0000530"}
{"ref-id":"A186038","pubmed-id":11939551,"citation":"Shibukawa A, Ishizawa N, Kimura T, Sakamoto Y, Ogita K, Matsuo Y, Kuroda Y, Matayatsu C, Nakagawa T, Wainer IW: Plasma protein binding study of oxybutynin by high-performance frontal analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 25;768(1):177-88.","parent_key":"BE0000925"}
{"ref-id":"A186041","pubmed-id":11939552,"citation":"Shibukaw A, Yoshikawa Y, Kimura T, Kuroda Y, Nakagawa T, Wainer IW: Binding study of desethyloxybutynin using high-performance frontal analysis method. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 25;768(1):189-97.","parent_key":"BE0000925"}
{"ref-id":"A186038","pubmed-id":11939551,"citation":"Shibukawa A, Ishizawa N, Kimura T, Sakamoto Y, Ogita K, Matsuo Y, Kuroda Y, Matayatsu C, Nakagawa T, Wainer IW: Plasma protein binding study of oxybutynin by high-performance frontal analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 25;768(1):177-88.","parent_key":"BE0000530"}
{"ref-id":"A186041","pubmed-id":11939552,"citation":"Shibukaw A, Yoshikawa Y, Kimura T, Kuroda Y, Nakagawa T, Wainer IW: Binding study of desethyloxybutynin using high-performance frontal analysis method. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 25;768(1):189-97.","parent_key":"BE0000530"}
{"ref-id":"A15504","pubmed-id":3424402,"citation":"Pacifici GM, Viani A, Rizzo G, Carrai M, Rane A: Plasma protein binding of clonazepam in hepatic and renal insufficiency and after hemodialysis. Ther Drug Monit. 1987 Dec;9(4):369-73.","parent_key":"BE0000530"}
{"ref-id":"A190132","pubmed-id":27315330,"citation":"He LL, Wang ZX, Wang YX, Liu XP, Yang YJ, Gao YP, Wang X, Liu B, Wang X: Studies on the interaction between promethazine and human serum albumin in the presence of flavonoids by spectroscopic and molecular modeling techniques. Colloids Surf B Biointerfaces. 2016 Sep 1;145:820-829. doi: 10.1016/j.colsurfb.2016.06.001. Epub 2016 Jun 2.","parent_key":"BE0000530"}
{"ref-id":"A177397","pubmed-id":28613530,"citation":"McIver LA, Siddique MS: Atorvastatin .","parent_key":"BE0000530"}
{"ref-id":"A20260","pubmed-id":26471709,"citation":"Shahlaei M, Rahimi B, Nowroozi A, Ashrafi-Kooshk MR, Sadrjavadi K, Khodarahmi R: Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem Biol Interact. 2015 Dec 5;242:235-46. doi: 10.1016/j.cbi.2015.10.006. Epub 2015 Oct 22.","parent_key":"BE0000530"}
{"ref-id":"A214463","pubmed-id":25376919,"citation":"Hu Z, Zhang J, Cheng X: Antifungal efficiency of miconazole and econazole and the interaction with transport protein: a comparative study. Pharm Biol. 2015 Feb;53(2):251-61. doi: 10.3109/13880209.2014.914232. Epub 2014 Nov 7.","parent_key":"BE0000530"}
{"ref-id":"A190207","pubmed-id":2872322,"citation":"Otto J, Lesko LJ: Protein binding of nifedipine. J Pharm Pharmacol. 1986 May;38(5):399-400. doi: 10.1111/j.2042-7158.1986.tb04598.x.","parent_key":"BE0000530"}
{"ref-id":"A190207","pubmed-id":2872322,"citation":"Otto J, Lesko LJ: Protein binding of nifedipine. J Pharm Pharmacol. 1986 May;38(5):399-400. doi: 10.1111/j.2042-7158.1986.tb04598.x.","parent_key":"BE0004879"}
{"ref-id":"A189814","pubmed-id":3242577,"citation":"Veronese ME, McLean S, Hendriks R: Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method. Br J Clin Pharmacol. 1988 Dec;26(6):721-31. doi: 10.1111/j.1365-2125.1988.tb05311.x.","parent_key":"BE0000530"}
{"ref-id":"A189817","pubmed-id":3972082,"citation":"Neyroz P, Bonati M: In vitro amiodarone protein binding and its interaction with warfarin. Experientia. 1985 Mar 15;41(3):361-3. doi: 10.1007/bf02004505.","parent_key":"BE0000530"}
{"ref-id":"A189820","pubmed-id":6146666,"citation":"Lalloz MR, Byfield PG, Greenwood RM, Himsworth RL: Binding of amiodarone by serum proteins and the effects of drugs, hormones and other interacting ligands. J Pharm Pharmacol. 1984 Jun;36(6):366-72. doi: 10.1111/j.2042-7158.1984.tb04400.x.","parent_key":"BE0000530"}
{"ref-id":"A12437","pubmed-id":1576681,"citation":"Igaki A, Kobayashi K, Kimura M, Sakoguchi T, Matsuoka A: Influence of blood proteins on biomedical analysis. XII. Effects of glycation on gliclazide (oral hypoglycemic drug)-binding with serum albumin in diabetics. Chem Pharm Bull (Tokyo). 1992 Jan;40(1):255-7.","parent_key":"BE0000530"}
{"ref-id":"A12438","pubmed-id":7094168,"citation":"Kobayashi K, Kimura M, Sakoguchi T, Hase A, Matsuoka A: Influence of blood proteins on biomedical analysis. V. Effect of ethyl alcohol on gliclazide-binding with bovine serum albumin. Chem Pharm Bull (Tokyo). 1982 Mar;30(3):1077-80.","parent_key":"BE0000530"}
{"ref-id":"A20109","pubmed-id":19596536,"citation":"Marszall MP, Bucinski A: A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J Pharm Biomed Anal. 2010 Jul 8;52(3):420-4. doi: 10.1016/j.jpba.2009.06.023. Epub 2009 Jun 18.","parent_key":"BE0000530"}
{"ref-id":"A1944","pubmed-id":7113722,"citation":"Virtanen R, Iisalo E, Irjala K: Protein binding of doxepin and desmethyldoxepin. Acta Pharmacol Toxicol (Copenh). 1982 Aug;51(2):159-64.","parent_key":"BE0000530"}
{"ref-id":"A1944","pubmed-id":7113722,"citation":"Virtanen R, Iisalo E, Irjala K: Protein binding of doxepin and desmethyldoxepin. Acta Pharmacol Toxicol (Copenh). 1982 Aug;51(2):159-64.","parent_key":"BE0000925"}
{"ref-id":"A15506","pubmed-id":7356894,"citation":"Friedman LA, Lewis PJ: The effect of semisynthetic penicillins on the binding of bilirubin by neonatal serum. Br J Clin Pharmacol. 1980 Jan;9(1):61-5.","parent_key":"BE0000530"}
{"ref-id":"A15507","pubmed-id":8024646,"citation":"Okore VC: Effect of ascorbic acid on the binding of cloxacillin sodium to bovine serum albumin. Arzneimittelforschung. 1994 May;44(5):671-3.","parent_key":"BE0000530"}
{"ref-id":"A20253","pubmed-id":25863441,"citation":"Shooshtary S, Behtash S, Nafisi S: Arsenic trioxide binding to serum proteins. J Photochem Photobiol B. 2015 Jul;148:31-36. doi: 10.1016/j.jphotobiol.2015.03.001. Epub 2015 Apr 1.","parent_key":"BE0000530"}
{"ref-id":"A186853","pubmed-id":6364769,"citation":"Conard GJ, Ober RE: Metabolism of flecainide. Am J Cardiol. 1984 Feb 27;53(5):41B-51B. doi: 10.1016/0002-9149(84)90501-0.","parent_key":"BE0004879"}
{"ref-id":"A186853","pubmed-id":6364769,"citation":"Conard GJ, Ober RE: Metabolism of flecainide. Am J Cardiol. 1984 Feb 27;53(5):41B-51B. doi: 10.1016/0002-9149(84)90501-0.","parent_key":"BE0000530"}
{"ref-id":"A15241","pubmed-id":8216349,"citation":"Keire DA, Mariappan SV, Peng J, Rabenstein DL: Nuclear magnetic resonance studies of the binding of captopril and penicillamine by serum albumin. Biochem Pharmacol. 1993 Sep 14;46(6):1059-69.","parent_key":"BE0000530"}
{"ref-id":"A15242","pubmed-id":15093593,"citation":"Lin SY, Wei YS, Li MJ, Wang SL: Effect of ethanol or/and captopril on the secondary structure of human serum albumin before and after protein binding. Eur J Pharm Biopharm. 2004 May;57(3):457-64.","parent_key":"BE0000530"}
{"ref-id":"A15243","pubmed-id":16469467,"citation":"Mariee AD, Al-Shabanah O: Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus. J Pharm Biomed Anal. 2006 May 3;41(2):571-5. Epub 2006 Feb 15.","parent_key":"BE0000530"}
{"ref-id":"A15244","pubmed-id":9040098,"citation":"Narazaki R, Harada K, Sugii A, Otagiri M: Kinetic analysis of the covalent binding of captopril to human serum albumin. J Pharm Sci. 1997 Feb;86(2):215-9.","parent_key":"BE0000530"}
{"ref-id":"A182366","pubmed-id":6146679,"citation":"Patel L, Johnson A, Turner P: Nadolol binding to human serum proteins. J Pharm Pharmacol. 1984 Jun;36(6):414-5. doi: 10.1111/j.2042-7158.1984.tb04413.x.","parent_key":"BE0004879"}
{"ref-id":"A182372","pubmed-id":11495502,"citation":"Israili ZH, Dayton PG: Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab Rev. 2001 May;33(2):161-235. doi: 10.1081/DMR-100104402 .","parent_key":"BE0004879"}
{"ref-id":"A12632","pubmed-id":2311445,"citation":"Gulian JM, Dalmasso C, Gonard V: Interaction of beta-lactam antibiotics on bilirubin-albumin complex: comparison by three methods, total bilirubin, unbound bilirubin and erythrocyte-bound bilirubin. Chemotherapy. 1990;36(2):91-7.","parent_key":"BE0000530"}
{"ref-id":"A12634","pubmed-id":8950041,"citation":"Nerli B, Farruggia B, Pico G: A comparative study of the binding characteristics of ceftriaxone, cefoperazone and cefsulodin to human serum albumin. Biochem Mol Biol Int. 1996 Nov;40(4):823-31.","parent_key":"BE0000530"}
{"ref-id":"A15499","pubmed-id":11181499,"citation":"Holladay JW, Dewey MJ, Michniak BB, Wiltshire H, Halberg DL, Weigl P, Liang Z, Halifax K, Lindup WE, Back DJ: Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir. Drug Metab Dispos. 2001 Mar;29(3):299-303.","parent_key":"BE0000925"}
{"ref-id":"A15499","pubmed-id":11181499,"citation":"Holladay JW, Dewey MJ, Michniak BB, Wiltshire H, Halberg DL, Weigl P, Liang Z, Halifax K, Lindup WE, Back DJ: Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir. Drug Metab Dispos. 2001 Mar;29(3):299-303.","parent_key":"BE0000530"}
{"ref-id":"A185000","pubmed-id":3964535,"citation":"Webb D, Buss DC, Fifield R, Bateman DN, Routledge PA: The plasma protein binding of metoclopramide in health and renal disease. Br J Clin Pharmacol. 1986 Mar;21(3):334-6. doi: 10.1111/j.1365-2125.1986.tb05201.x.","parent_key":"BE0000925"}
{"ref-id":"A188559","pubmed-id":2316228,"citation":"Cummings DM, Larijani GE, Conner DP, Ferguson RK, Rocci ML Jr: Characterization of dexamethasone binding in normal and uremic human serum. DICP. 1990 Mar;24(3):229-31. doi: 10.1177/106002809002400301.","parent_key":"BE0000530"}
{"ref-id":"A177814","pubmed-id":25209359,"citation":"Yeggoni DP, Subramanyam R: Binding studies of L-3,4-dihydroxyphenylalanine with human serum albumin. Mol Biosyst. 2014 Dec;10(12):3101-10. doi: 10.1039/c4mb00408f. Epub 2014 Sep 11.","parent_key":"BE0000530"}
{"ref-id":"A185798","pubmed-id":9010630,"citation":"Sallustio BC, Fairchild BA, Pannall PR: Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide. Drug Metab Dispos. 1997 Jan;25(1):55-60.","parent_key":"BE0000530"}
{"ref-id":"A185804","pubmed-id":3468088,"citation":"Hamberger C, Barre J, Zini R, Taiclet A, Houin G, Tillement JP: In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs. Int J Clin Pharmacol Res. 1986;6(6):441-9.","parent_key":"BE0000530"}
{"ref-id":"A191490","pubmed-id":23143899,"citation":"Croteau D, Rossi SS, Best BM, Capparelli E, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Grant I, Letendre S: Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. J Antimicrob Chemother. 2013 Mar;68(3):684-9. doi: 10.1093/jac/dks441. Epub 2012 Nov 9.","parent_key":"BE0000530"}
{"ref-id":"A191493","pubmed-id":28753530,"citation":"Shi JH, Zhou KL, Lou YY, Pan DQ: Multi-spectroscopic and molecular modeling approaches to elucidate the binding interaction between bovine serum albumin and darunavir, a HIV protease inhibitor. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jan 5;188:362-371. doi: 10.1016/j.saa.2017.07.040. Epub 2017 Jul 23.","parent_key":"BE0000530"}
{"ref-id":"A191496","pubmed-id":19320601,"citation":"Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslen M: Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses. 2009 Apr;25(4):457-61. doi: 10.1089/aid.2008.0216.","parent_key":"BE0000530"}
{"ref-id":"A191490","pubmed-id":23143899,"citation":"Croteau D, Rossi SS, Best BM, Capparelli E, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Grant I, Letendre S: Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. J Antimicrob Chemother. 2013 Mar;68(3):684-9. doi: 10.1093/jac/dks441. Epub 2012 Nov 9.","parent_key":"BE0000925"}
{"ref-id":"A191496","pubmed-id":19320601,"citation":"Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslen M: Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses. 2009 Apr;25(4):457-61. doi: 10.1089/aid.2008.0216.","parent_key":"BE0000925"}
{"ref-id":"A186304","citation":"Bolattin M, Nandibewoor S, Joshi S, Dixit S, Chimatadar S: Interaction of Hydralazine with Human Serum Albumin and Effect of N2-Cyclodextrin on Binding: Insights from Spectroscopic and Molecular Docking Techniques Industrial & Engineering Chemistry Research. 2016 Apr 24;55(19):5454-5464.","parent_key":"BE0000530"}
{"ref-id":"A20114","pubmed-id":19900495,"citation":"Chae SY, Jin CH, Shin JH, Son S, Kim TH, Lee S, Youn YS, Byun Y, Lee MS, Lee KC: Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs. J Control Release. 2010 Mar 3;142(2):206-13. doi: 10.1016/j.jconrel.2009.10.025.  Epub 2009 Nov 10.","parent_key":"BE0000530"}
{"ref-id":"A16835","pubmed-id":11110794,"citation":"Sun H, Li H, Mason AB, Woodworth RC, Sadler PJ: Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma. J Biol Chem. 2001 Mar 23;276(12):8829-35. Epub 2000 Dec 7.","parent_key":"BE0000530"}
{"ref-id":"A16836","pubmed-id":12620681,"citation":"Sun H, Szeto KY: Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma. J Inorg Biochem. 2003 Feb 1;94(1-2):114-20.","parent_key":"BE0000530"}
{"ref-id":"A3239","pubmed-id":17391154,"citation":"Klein O, Lynge J, Endahl L, Damholt B, Nosek L, Heise T: Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes. Diabetes Obes Metab. 2007 May;9(3):290-9.","parent_key":"BE0000530"}
{"ref-id":"A2358","pubmed-id":17881328,"citation":"Kurtzhals P: Pharmacology of insulin detemir. Endocrinol Metab Clin North Am. 2007 Aug;36 Suppl 1:14-20.","parent_key":"BE0000530"}
{"ref-id":"A15745","pubmed-id":8577822,"citation":"Walker MC, Patsalos PN: Clinical pharmacokinetics of new antiepileptic drugs. Pharmacol Ther. 1995;67(3):351-84.","parent_key":"BE0000530"}
{"ref-id":"A16729","pubmed-id":20528637,"citation":"Duarte JD, Cooper-DeHoff RM: Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther. 2010 Jun;8(6):793-802. doi: 10.1586/erc.10.27.","parent_key":"BE0000530"}
{"ref-id":"A15508","pubmed-id":3395358,"citation":"Decroix MO, Zini R, Chaumeil JC, Tillement JP: Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs. Biochem Pharmacol. 1988 Jul 15;37(14):2807-14.","parent_key":"BE0000530"}
{"ref-id":"A15509","pubmed-id":2292768,"citation":"Ichimura F, Matsushita R, Tsuji A, Deguchi Y: Mutual interaction between bilirubin and cefazolin in binding to human serum albumin. J Pharm Sci. 1990 Nov;79(11):1041-2.","parent_key":"BE0000530"}
{"ref-id":"A12628","pubmed-id":1804013,"citation":"Rodriguez CA, Smith DE: Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys. Antimicrob Agents Chemother. 1991 Nov;35(11):2395-400.","parent_key":"BE0000530"}
{"ref-id":"A12630","pubmed-id":8328784,"citation":"Benson JM, Boudinot FD, Pennell AT, Cunningham FE, DiPiro JT: In vitro protein binding of cefonicid and cefuroxime in adult and neonatal sera. Antimicrob Agents Chemother. 1993 Jun;37(6):1343-7.","parent_key":"BE0000530"}
{"ref-id":"A12631","pubmed-id":16379298,"citation":"Liu LS, Zhang YY, Wang XP: [The reaction mechanism between cefoperazone and human serum albumin]. Guang Pu Xue Yu Guang Pu Fen Xi. 2005 Sep;25(9):1490-2.","parent_key":"BE0000530"}
{"ref-id":"A12633","pubmed-id":2496656,"citation":"Leggett JE, Craig WA: Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli. Antimicrob Agents Chemother. 1989 Jan;33(1):35-40.","parent_key":"BE0000530"}
{"ref-id":"A2413","pubmed-id":1974610,"citation":"Martinez Jorda R, Aguirre C, Calvo R, Rodriguez-Sasiain JM, Erill S: Decrease in penbutolol central response as a cause of changes in its serum protein binding. J Pharm Pharmacol. 1990 Mar;42(3):164-6.","parent_key":"BE0000925"}
{"ref-id":"A2409","pubmed-id":8174208,"citation":"Aguirre C, Rodriguez-Sasiain JM, Calvo R: Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents. Cancer Chemother Pharmacol. 1994;34(1):86-8.","parent_key":"BE0000925"}
{"ref-id":"A12650","pubmed-id":8444514,"citation":"Aguirre C, Calvo R, Rodriguez-Sasiain JM: Unchanged protein binding of penbutolol in renal insufficiency: a possible role of carbamylation. Int J Clin Pharmacol Ther Toxicol. 1993 Jan;31(1):31-4.","parent_key":"BE0000925"}
{"ref-id":"A12651","pubmed-id":8733828,"citation":"Aguirre C, Troconiz IF, Valdivieso A, Jimenez RM, Gonzalez JP, Calvo R, Rodriguez-Sasiain JM: Pharmacokinetics and pharmacodynamics of penbutolol in healthy and cancer subjects: role of altered protein binding. Res Commun Mol Pathol Pharmacol. 1996 Apr;92(1):53-72.","parent_key":"BE0000925"}
{"ref-id":"A19881","pubmed-id":12921780,"citation":"Zatta P, Dalla Via L, Di Noto V: Binding studies on aluminum(III)-albumin interaction. Arch Biochem Biophys. 2003 Sep 1;417(1):59-64.","parent_key":"BE0000530"}
{"ref-id":"A183893","pubmed-id":16239027,"citation":"Hu YJ, Liu Y, Zhao RM, Qu SS: Interaction of colchicine with human serum albumin investigated by spectroscopic methods. Int J Biol Macromol. 2005 Nov 15;37(3):122-6. doi: 10.1016/j.ijbiomac.2005.09.007. Epub 2005 Oct 18.","parent_key":"BE0000530"}
{"ref-id":"A183896","pubmed-id":572067,"citation":"Trnavska Z, Kuchar M, Rejholec V, Trnavsky K: The binding of colchicine and its derivatives to bovine and human serum albumin and human plasma. Pharmacology. 1979;18(3):123-7. doi: 10.1159/000137240.","parent_key":"BE0000530"}
{"ref-id":"A183899","pubmed-id":19615934,"citation":"Maciazek-Jurczyk M, Sulkowska A, Bojko B, Rownicka-Zubik J, Sulkowski WW: Interaction of phenylbutazone and colchicine in binding to serum albumin in rheumatoid therapy: 1H NMR study. Spectrochim Acta A Mol Biomol Spectrosc. 2009 Sep 15;74(1):1-9. doi: 10.1016/j.saa.2009.06.043. Epub 2009 Jun 25.","parent_key":"BE0000530"}
{"ref-id":"A12683","pubmed-id":10202961,"citation":"Hage DS, Sengupta A: Characterisation of the binding of digitoxin and acetyldigitoxin to human serum albumin by high-performance affinity chromatography. J Chromatogr B Biomed Sci Appl. 1999 Mar 5;724(1):91-100.","parent_key":"BE0000530"}
{"ref-id":"A12684","pubmed-id":10604823,"citation":"Dasgupta A, Vega AE, Wells A, Datta P: Sensitive methods for determination of free digitoxin concentration using digitoxin immunoassays: demonstration of elevated free digitoxin concentration caused by digitoxin-phenytoin interaction by applying these new techniques. Ther Drug Monit. 1999 Dec;21(6):625-30.","parent_key":"BE0000530"}
{"ref-id":"A12685","pubmed-id":10774625,"citation":"Datta P, Dasgupta A: Interactions between drugs and Asian medicine: displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicines Chan Su and Lu-Shen-Wan. Ther Drug Monit. 2000 Apr;22(2):155-9.","parent_key":"BE0000530"}
{"ref-id":"A12686","pubmed-id":11678517,"citation":"Dasgupta A, Paul A, Wells A: Uremic sera contain inhibitors that block digitoxin-valproic acid interaction. Am J Med Sci. 2001 Oct;322(4):204-8.","parent_key":"BE0000530"}
{"ref-id":"A14239","pubmed-id":18436441,"citation":"Zhang Q, Huang Y, Zhao R, Liu G, Chen Y: Determining binding sites of drugs on human serum albumin using FIA-QCM. Biosens Bioelectron. 2008 Sep 15;24(1):48-54. doi: 10.1016/j.bios.2008.03.009. Epub 2008 Mar 21.","parent_key":"BE0000530"}
{"ref-id":"A15473","pubmed-id":8398591,"citation":"Fitos I, Visy J, Simonyi M, Hermansson J: Stereoselective distribution of acenocoumarol enantiomers in human plasma: chiral chromatographic analysis of the ultrafiltrates. Chirality. 1993;5(5):346-9.","parent_key":"BE0000530"}
{"ref-id":"A15474","pubmed-id":2751692,"citation":"Fitos I, Visy J, Magyar A, Kajtar J, Simonyi M: Inverse stereoselectivity in the binding of acenocoumarol to human serum albumin and to alpha 1-acid glycoprotein. Biochem Pharmacol. 1989 Jul 15;38(14):2259-62.","parent_key":"BE0000530"}
{"ref-id":"A15475","pubmed-id":6105183,"citation":"Otagiri M, Fleitman JS, Perrin JH: Investigations into the binding of phenprocoumon to albumin using fluorescence spectroscopy. J Pharm Pharmacol. 1980 Jul;32(7):478-82.","parent_key":"BE0000530"}
{"ref-id":"A15473","pubmed-id":8398591,"citation":"Fitos I, Visy J, Simonyi M, Hermansson J: Stereoselective distribution of acenocoumarol enantiomers in human plasma: chiral chromatographic analysis of the ultrafiltrates. Chirality. 1993;5(5):346-9.","parent_key":"BE0000925"}
{"ref-id":"A15474","pubmed-id":2751692,"citation":"Fitos I, Visy J, Magyar A, Kajtar J, Simonyi M: Inverse stereoselectivity in the binding of acenocoumarol to human serum albumin and to alpha 1-acid glycoprotein. Biochem Pharmacol. 1989 Jul 15;38(14):2259-62.","parent_key":"BE0000925"}
{"ref-id":"A17107","pubmed-id":2591421,"citation":"Koppel C, Wagemann A, Martens F: Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset. Eur J Drug Metab Pharmacokinet. 1989 Apr-Jun;14(2):161-7.","parent_key":"BE0000925"}
{"ref-id":"A12732","pubmed-id":7075647,"citation":"Teirlynck O, Belpaire FM, Andreasen F: Binding of aprindine and moxaprindine to human serum, alpha 1-acid glycoprotein and serum of healthy and diseased humans. Eur J Clin Pharmacol. 1982;21(5):427-31.","parent_key":"BE0000925"}
{"ref-id":"A181247","pubmed-id":19566112,"citation":"Doroshyenko O, Fuhr U: Clinical pharmacokinetics and pharmacodynamics of solifenacin. Clin Pharmacokinet. 2009;48(5):281-302. doi: 10.2165/00003088-200948050-00001.","parent_key":"BE0004879"}
{"ref-id":"A183047","pubmed-id":8803904,"citation":"Furst DE: Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lupus. 1996 Jun;5 Suppl 1:S11-5.","parent_key":"BE0000530"}
{"ref-id":"A183047","pubmed-id":8803904,"citation":"Furst DE: Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lupus. 1996 Jun;5 Suppl 1:S11-5.","parent_key":"BE0004879"}
{"ref-id":"A193041","pubmed-id":26886739,"citation":"Ranganarayanan P, Thanigesan N, Ananth V, Jayaraman VK, Ramakrishnan V: Identification of Glucose-Binding Pockets in Human Serum Albumin Using Support Vector Machine and Molecular Dynamics Simulations. IEEE/ACM Trans Comput Biol Bioinform. 2016 Jan-Feb;13(1):148-57. doi: 10.1109/TCBB.2015.2415806.","parent_key":"BE0000530"}
{"ref-id":"A20061","pubmed-id":17597382,"citation":"Lu Z, Zhang Y, Liu H, Yuan J, Zheng Z, Zou G: Transport of a cancer chemopreventive polyphenol, resveratrol: interaction with serum albumin and hemoglobin. J Fluoresc. 2007 Sep;17(5):580-7. Epub 2007 Jun 28.","parent_key":"BE0000530"}
{"ref-id":"A1713","pubmed-id":17139284,"citation":"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.","parent_key":"BE0000530"}
{"ref-id":"A1715","pubmed-id":17016423,"citation":"Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.","parent_key":"BE0000530"}
{"ref-id":"A12906","pubmed-id":16184009,"citation":"Yamazaki E, Inagaki M, Kurita O, Inoue T: Kinetics of fatty acid binding ability of glycated human serum albumin. J Biosci. 2005 Sep;30(4):475-81.","parent_key":"BE0000530"}
{"ref-id":"A12913","pubmed-id":5773785,"citation":"Spector AA, John K, Fletcher JE: Binding of long-chain fatty acids to bovine serum albumin. J Lipid Res. 1969 Jan;10(1):56-67.","parent_key":"BE0000530"}
{"ref-id":"A12922","pubmed-id":8014580,"citation":"Kenyon MA, Hamilton JA: 13C NMR studies of the binding of medium-chain fatty acids to human serum albumin. J Lipid Res. 1994 Mar;35(3):458-67.","parent_key":"BE0000530"}
{"ref-id":"A12923","pubmed-id":1483836,"citation":"Vorum H, Pedersen AO, Honore B: Fatty acid and drug binding to a low-affinity component of human serum albumin, purified by affinity chromatography. Int J Pept Protein Res. 1992 Nov;40(5):415-22.","parent_key":"BE0000530"}
{"ref-id":"A12925","pubmed-id":16844140,"citation":"Simard JR, Zunszain PA, Hamilton JA, Curry S: Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. J Mol Biol. 2006 Aug 11;361(2):336-51. Epub 2006 Jun 30.","parent_key":"BE0000530"}
{"ref-id":"A19952","pubmed-id":15884859,"citation":"Kaldas MI, Walle UK, van der Woude H, McMillan JM, Walle T: Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem. 2005 May 18;53(10):4194-7.","parent_key":"BE0000530"}
{"ref-id":"A12930","pubmed-id":11743713,"citation":"Petitpas I, Grune T, Bhattacharya AA, Curry S: Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol. 2001 Dec 14;314(5):955-60.","parent_key":"BE0000530"}
{"ref-id":"A20074","pubmed-id":18035550,"citation":"Yue Y, Zhang Y, Zhou L, Qin J, Chen X: In vitro study on the binding of herbicide glyphosate to human serum albumin by optical spectroscopy and molecular modeling. J Photochem Photobiol B. 2008 Jan 30;90(1):26-32. Epub 2007 Oct 18.","parent_key":"BE0000530"}
{"ref-id":"A20051","pubmed-id":23838380,"citation":"Wang ZM, Ho JX, Ruble JR, Rose J, Ruker F, Ellenburg M, Murphy R, Click J, Soistman E, Wilkerson L, Carter DC: Structural studies of several clinically important oncology drugs in complex with human serum albumin. Biochim Biophys Acta. 2013 Dec;1830(12):5356-74. doi: 10.1016/j.bbagen.2013.06.032. Epub 2013 Jul 6.","parent_key":"BE0000530"}
{"ref-id":"A2681","pubmed-id":925927,"citation":"Lin SK, Moss AA, Riegelman S: Iodipamide kinetics: capacity-limited biliary excretion with simultaneous pseudo-first-order renal excretion. J Pharm Sci. 1977 Dec;66(12):1670-4.","parent_key":"BE0000530"}
{"ref-id":"A19979","pubmed-id":16404478,"citation":"Skupinska K, Zylm M, Misiewicz I, Kasprzycka-Guttman T: Interaction of anthracene and its oxidative derivatives with human serum albumin. Acta Biochim Pol. 2006;53(1):101-12. Epub 2006 Jan 9.","parent_key":"BE0000530"}
{"ref-id":"A20269","pubmed-id":6627828,"citation":"Pritchard JF, O'Neill PJ, Affrime MB, Lowenthal DT: Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding. Clin Pharmacol Ther. 1983 Nov;34(5):681-8.","parent_key":"BE0000530"}
{"ref-id":"A193398","pubmed-id":19349514,"citation":"McKay GA, Beaulieu S, Sarmiento I, Arhin FF, Parr TR Jr, Moeck G: Impact of human serum albumin on oritavancin in vitro activity against enterococci. Antimicrob Agents Chemother. 2009 Jun;53(6):2687-9. doi: 10.1128/AAC.00197-09. Epub 2009 Apr 6.","parent_key":"BE0000530"}
{"ref-id":"A20082","pubmed-id":18393300,"citation":"Guo W, Siegel D, Ross D: Stability of the Hsp90 inhibitor 17AAG hydroquinone and prevention of metal-catalyzed oxidation. J Pharm Sci. 2008 Dec;97(12):5147-57. doi: 10.1002/jps.21394.","parent_key":"BE0000530"}
{"ref-id":"A192171","pubmed-id":16811063,"citation":"Acland JD: The interpretation of the serum protein-bound iodine: A review. J Clin Pathol. 1971 Apr;24(3):187-218. doi: 10.1136/jcp.24.3.187.","parent_key":"BE0000530"}
{"ref-id":"A3672","pubmed-id":22954756,"citation":"Garg V, Kauffman RS, Beaumont M, van Heeswijk RP: Telaprevir: pharmacokinetics and drug interactions. Antivir Ther. 2012;17(7):1211-21. doi: 10.3851/IMP2356. Epub 2012 Sep 7.","parent_key":"BE0000530"}
{"ref-id":"A3672","pubmed-id":22954756,"citation":"Garg V, Kauffman RS, Beaumont M, van Heeswijk RP: Telaprevir: pharmacokinetics and drug interactions. Antivir Ther. 2012;17(7):1211-21. doi: 10.3851/IMP2356. Epub 2012 Sep 7.","parent_key":"BE0000925"}
{"ref-id":"A3811","pubmed-id":23199349,"citation":"Ryan CJ, Cheng ML: Abiraterone acetate for the treatment of prostate cancer. Expert Opin Pharmacother. 2013 Jan;14(1):91-6. doi: 10.1517/14656566.2013.745852. Epub 2012 Nov 30.","parent_key":"BE0000530"}
{"ref-id":"A3811","pubmed-id":23199349,"citation":"Ryan CJ, Cheng ML: Abiraterone acetate for the treatment of prostate cancer. Expert Opin Pharmacother. 2013 Jan;14(1):91-6. doi: 10.1517/14656566.2013.745852. Epub 2012 Nov 30.","parent_key":"BE0000925"}
{"ref-id":"A181781","pubmed-id":19857990,"citation":"Liu X, Du Y, Sun W, Kou J, Yu B: Study on the interaction of levocetirizine dihydrochloride with human serum albumin by molecular spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc. 2009 Dec;74(5):1189-96. doi: 10.1016/j.saa.2009.09.033. Epub 2009 Oct 4.","parent_key":"BE0000530"}
{"ref-id":"A177673","citation":"Knudsen B, Jesper Lau: The Discovery and Development of Liraglutide and Semaglutide Frontiers in Endocrinology.","parent_key":"BE0000530"}
{"ref-id":"A17104","pubmed-id":17650553,"citation":"Meaney JF, Goyen M: Recent advances in contrast-enhanced magnetic resonance angiography. Eur Radiol. 2007 Mar;17 Suppl 2:B2-6.","parent_key":"BE0000530"}
{"ref-id":"A7009","pubmed-id":19222207,"citation":"Caravan P: Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc Chem Res. 2009 Jul 21;42(7):851-62. doi: 10.1021/ar800220p.","parent_key":"BE0000530"}
{"ref-id":"A17105","pubmed-id":17625839,"citation":"Caravan P, Parigi G, Chasse JM, Cloutier NJ, Ellison JJ, Lauffer RB, Luchinat C, McDermid SA, Spiller M, McMurry TJ: Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. Inorg Chem. 2007 Aug 6;46(16):6632-9. Epub 2007 Jul 11.","parent_key":"BE0000530"}
{"ref-id":"A17106","pubmed-id":16706555,"citation":"Henness S, Keating GM: Gadofosveset. Drugs. 2006;66(6):851-7.","parent_key":"BE0000530"}
{"ref-id":"A19708","pubmed-id":9245963,"citation":"Toft KG, Hustvedt SO, Grant D, Martinsen I, Gordon PB, Friisk GA, Korsmo AJ, Skotland T: Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 1997 Jul;38(4 Pt 2):677-89.","parent_key":"BE0000530"}
{"ref-id":"A19709","pubmed-id":9245964,"citation":"Hustvedt SO, Grant D, Southon TE, Zech K: Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol. 1997 Jul;38(4 Pt 2):690-9.","parent_key":"BE0000530"}
{"ref-id":"A192993","pubmed-id":708450,"citation":"Vodrazka Z, Jandova D, Grafnetterova J, Schuck O, Kalousek I, Tomaasek R, Lachmanova J: The binding of chloramphenicol to albumin of normal and uremic sera. Biochem Pharmacol. 1978;27(13):1717-20. doi: 10.1016/0006-2952(78)90545-2.","parent_key":"BE0000530"}
{"ref-id":"A204152","pubmed-id":30167561,"citation":"Angheloiu GO, Gugiu GB, Ruse C, Pandey R, Dasari RR, Whatling C: Ticagrelor Removal From Human Blood. JACC Basic Transl Sci. 2017 Apr 24;2(2):135-145. doi: 10.1016/j.jacbts.2017.01.007. eCollection 2017 Apr.","parent_key":"BE0000530"}
{"ref-id":"A179758","pubmed-id":25707701,"citation":"Schneider EK, Huang JX, Carbone V, Baker M, Azad MA, Cooper MA, Li J, Velkov T: Drug-drug plasma protein binding interactions of ivacaftor. J Mol Recognit. 2015 Jun;28(6):339-48. doi: 10.1002/jmr.2447. Epub 2015 Feb 24.","parent_key":"BE0000530"}
{"ref-id":"A179758","pubmed-id":25707701,"citation":"Schneider EK, Huang JX, Carbone V, Baker M, Azad MA, Cooper MA, Li J, Velkov T: Drug-drug plasma protein binding interactions of ivacaftor. J Mol Recognit. 2015 Jun;28(6):339-48. doi: 10.1002/jmr.2447. Epub 2015 Feb 24.","parent_key":"BE0000925"}
{"ref-id":"A7491","pubmed-id":23590413,"citation":"Lamos EM, Younk LM, Davis SN: Canagliflozin , an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus. Expert Opin Drug Metab Toxicol. 2013 Jun;9(6):763-75. doi: 10.1517/17425255.2013.791282. Epub 2013 Apr 17.","parent_key":"BE0000925"}
{"ref-id":"A7528","pubmed-id":25395817,"citation":"Khaybullina D, Patel A, Zerilli T: Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. P T. 2014 Nov;39(11):749-58.","parent_key":"BE0000530"}
{"ref-id":"A7528","pubmed-id":25395817,"citation":"Khaybullina D, Patel A, Zerilli T: Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. P T. 2014 Nov;39(11):749-58.","parent_key":"BE0000925"}
{"ref-id":"A7663","pubmed-id":25488930,"citation":"Scheers E, Leclercq L, de Jong J, Bode N, Bockx M, Laenen A, Cuyckens F, Skee D, Murphy J, Sukbuntherng J, Mannens G: Absorption, metabolism, and excretion of oral (1)(4)C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men. Drug Metab Dispos. 2015 Feb;43(2):289-97. doi: 10.1124/dmd.114.060061. Epub 2014  Dec 8.","parent_key":"BE0000530"}
{"ref-id":"A7663","pubmed-id":25488930,"citation":"Scheers E, Leclercq L, de Jong J, Bode N, Bockx M, Laenen A, Cuyckens F, Skee D, Murphy J, Sukbuntherng J, Mannens G: Absorption, metabolism, and excretion of oral (1)(4)C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men. Drug Metab Dispos. 2015 Feb;43(2):289-97. doi: 10.1124/dmd.114.060061. Epub 2014  Dec 8.","parent_key":"BE0004879"}
{"ref-id":"A185123","pubmed-id":31016670,"citation":"Wind S, Schmid U, Freiwald M, Marzin K, Lotz R, Ebner T, Stopfer P, Dallinger C: Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib. Clin Pharmacokinet. 2019 Sep;58(9):1131-1147. doi: 10.1007/s40262-019-00766-0.","parent_key":"BE0000530"}
{"ref-id":"A31426","pubmed-id":740662,"citation":"Elliott HL, Macdougall AI: Aluminium studies in dialysis encephalopathy. Proc Eur Dial Transplant Assoc. 1978;15:157-63.","parent_key":"BE0000530"}
{"ref-id":"A190768","pubmed-id":31440205,"citation":"Rabah SA, Gowan IL, Pagnin M, Osman N, Richardson SJ: Thyroid Hormone Distributor Proteins During Development in Vertebrates. Front Endocrinol (Lausanne). 2019 Aug 8;10:506. doi: 10.3389/fendo.2019.00506. eCollection 2019.","parent_key":"BE0000530"}
{"ref-id":"A19518","pubmed-id":14652164,"citation":"Tapiero H, Townsend DM, Tew KD: Trace elements in human physiology and pathology. Copper. Biomed Pharmacother. 2003 Nov;57(9):386-98.","parent_key":"BE0000530"}
{"ref-id":"A19830","pubmed-id":11396981,"citation":"Bar-Or D, Rael LT, Lau EP, Rao NK, Thomas GW, Winkler JV, Yukl RL, Kingston RG, Curtis CG: An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun. 2001 Jun 15;284(3):856-62.","parent_key":"BE0000530"}
{"ref-id":"A19831","pubmed-id":12434198,"citation":"Sakata N, Moh A, Takebayashi S: Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Heart Vessels. 2002 Nov;17(1):22-9.","parent_key":"BE0000530"}
{"ref-id":"A19832","pubmed-id":14534351,"citation":"She YM, Narindrasorasak S, Yang S, Spitale N, Roberts EA, Sarkar B: Identification of metal-binding proteins in human hepatoma lines by immobilized metal affinity chromatography and mass spectrometry. Mol Cell Proteomics. 2003 Dec;2(12):1306-18. Epub 2003 Oct 7.","parent_key":"BE0000530"}
{"ref-id":"A19833","pubmed-id":15359738,"citation":"Smith SD, She YM, Roberts EA, Sarkar B: Using immobilized metal affinity chromatography, two-dimensional electrophoresis and mass spectrometry to identify hepatocellular proteins with copper-binding ability. J Proteome Res. 2004 Jul-Aug;3(4):834-40.","parent_key":"BE0000530"}
{"ref-id":"A31487","pubmed-id":20030420,"citation":"Deeks ED, Keating GM: Blonanserin: a review of its use in the management of schizophrenia. CNS Drugs. 2010 Jan;24(1):65-84. doi: 10.2165/11202620-000000000-00000.","parent_key":"BE0000530"}
{"ref-id":"A32033","pubmed-id":19450464,"citation":"Liu Z, Zheng X, Yang X, Wang E, Wang J: Affinity and specificity of levamlodipine-human serum albumin interactions: insights into its carrier function. Biophys J. 2009 May 20;96(10):3917-25. doi: 10.1016/j.bpj.2008.12.3965.","parent_key":"BE0000530"}
{"ref-id":"A192648","pubmed-id":25833007,"citation":"He LL, Wang YX, Wu XX, Liu XP, Wang X, Liu B, Wang X: Enhancement of the binding affinity of methylene blue to site I in human serum albumin by cupric and ferric ions. Luminescence. 2015 Dec;30(8):1380-8. doi: 10.1002/bio.2910. Epub 2015 Mar 31.","parent_key":"BE0000530"}
{"ref-id":"A192651","pubmed-id":7277192,"citation":"Kozaki A, Watanabe J: Dose dependency of apparent volumes of distribution for methylene blue in rabbits. J Pharmacobiodyn. 1981 Jan;4(1):49-57. doi: 10.1248/bpb1978.4.49.","parent_key":"BE0000530"}
{"ref-id":"A19796","pubmed-id":19122340,"citation":"Ohno T, Nakade S, Nakayama K, Kitagawa J, Miyabe H, Konomi T, Miyata Y: Population pharmacokinetic analysis of a novel muscarinic receptor antagonist, imidafenacin, in healthy volunteers and overactive bladder patients. Drug Metab Pharmacokinet. 2008;23(6):456-63.","parent_key":"BE0000530"}
{"ref-id":"A19796","pubmed-id":19122340,"citation":"Ohno T, Nakade S, Nakayama K, Kitagawa J, Miyabe H, Konomi T, Miyata Y: Population pharmacokinetic analysis of a novel muscarinic receptor antagonist, imidafenacin, in healthy volunteers and overactive bladder patients. Drug Metab Pharmacokinet. 2008;23(6):456-63.","parent_key":"BE0004879"}
{"ref-id":"A20259","pubmed-id":23684544,"citation":"Veerappan A, Eichhorn T, Zeino M, Efferth T, Schneider D: Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin. Phytomedicine. 2013 Aug 15;20(11):969-74. doi: 10.1016/j.phymed.2013.04.003. Epub 2013 May 16.","parent_key":"BE0000530"}
{"ref-id":"A178231","pubmed-id":30460547,"citation":"Deeks ED: Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection. Drugs. 2018 Nov;78(17):1817-1828. doi: 10.1007/s40265-018-1010-7.","parent_key":"BE0000530"}
{"ref-id":"A32080","pubmed-id":20641974,"citation":"Cheng KT: Sodium-2-[(3-butanoylamino-2,4,6-triiodo-phenyl)methyl]butanoate .","parent_key":"BE0000530"}
{"ref-id":"A32139","pubmed-id":4520401,"citation":"Pinckard RN, Hawkins D, Farr RS: The influence of acetylsalicyclic acid on the binding of acetrizoate to human albumin. Ann N Y Acad Sci. 1973 Nov 26;226:341-54.","parent_key":"BE0000530"}
{"ref-id":"A32152","pubmed-id":912815,"citation":"Mate U, Solomon JJ, Segal A: In vitro binding of beta-propiolactone to calf thymus DNA and mouse liver DNA to form 1-(2-carboxyethyl) adenine. Chem Biol Interact. 1977 Sep;18(3):327-36.","parent_key":"BE0000530"}
{"ref-id":"A20264","pubmed-id":26892221,"citation":"Ma X, He J, Yan J, Wang Q, Li H: Comparative analysis the binding affinity of mycophenolic sodium and meprednisone with human serum albumin: Insight by NMR relaxation data and docking simulation. Chem Biol Interact. 2016 Mar 25;248:52-9. doi: 10.1016/j.cbi.2016.02.009. Epub 2016 Feb 16.","parent_key":"BE0000530"}
{"ref-id":"A32624","pubmed-id":4169405,"citation":"Yamada T, Jones AE: Effect of thiocyanate, perchlorate and other anions on plasma protein-thyroid hormone interaction in vitro. Endocrinology. 1968 Jan;82(1):47-53. doi: 10.1210/endo-82-1-47.","parent_key":"BE0000530"}
{"ref-id":"A32625","pubmed-id":18124175,"citation":"SCATCHARD G, BLACK ES: The effect of salts on the isoionic and isoelectric points of proteins. J Phys Colloid Chem. 1949 Jan;53(1):88-99.","parent_key":"BE0000530"}
{"ref-id":"A32613","pubmed-id":12140178,"citation":"Yu KO, Narayanan L, Mattie DR, Godfrey RJ, Todd PN, Sterner TR, Mahle DA, Lumpkin MH, Fisher JW: The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat. Toxicol Appl Pharmacol. 2002 Jul 15;182(2):148-59.","parent_key":"BE0000530"}
{"ref-id":"A20283","pubmed-id":8831264,"citation":"Sakurai M, Ohsako M, Nagano M, Nakamura C, Tsuzuki O, Ichikawa M, Matsumoto Y: [Effect of human serum albumin on transport of drugs through human erythrocyte membranes]. Yakugaku Zasshi. 1996 Aug;116(8):630-8.","parent_key":"BE0000530"}
{"ref-id":"A32195","pubmed-id":874779,"citation":"Judis J: Binding of codeine, morphine, and methadone to human serum proteins. J Pharm Sci. 1977 Jun;66(6):802-6.","parent_key":"BE0000530"}
{"ref-id":"A32675","pubmed-id":22190922,"citation":"Shipton EA: New formulations of local anaesthetics-part I. Anesthesiol Res Pract. 2012;2012:546409. doi: 10.1155/2012/546409. Epub 2011 Dec  5.","parent_key":"BE0000925"}
{"ref-id":"A32675","pubmed-id":22190922,"citation":"Shipton EA: New formulations of local anaesthetics-part I. Anesthesiol Res Pract. 2012;2012:546409. doi: 10.1155/2012/546409. Epub 2011 Dec  5.","parent_key":"BE0000530"}
{"ref-id":"A32402","pubmed-id":8776564,"citation":"Lee YC, Park CK, Kim MS, Kim JH: In vitro study for staining and toxicity of rose bengal on cultured bovine corneal endothelial cells. Cornea. 1996 Jul;15(4):376-85.","parent_key":"BE0000530"}
{"ref-id":"A20078","pubmed-id":18197631,"citation":"Wu X, Liang H, O'Hara KA, Yalowich JC, Hasinoff BB: Thiol-modulated mechanisms of the cytotoxicity of thimerosal and inhibition of DNA topoisomerase II alpha. Chem Res Toxicol. 2008 Feb;21(2):483-93. doi: 10.1021/tx700341n. Epub 2008 Jan 16.","parent_key":"BE0000530"}
{"ref-id":"A188024","pubmed-id":30664965,"citation":"Abdelhameed AS, Alanazi AM, Bakheit AH, Hassan ES, Herqash RN, Almutairi FM: Novel BTK inhibitor acalabrutinib (ACP-196) tightly binds to site I of the human serum albumin as observed by spectroscopic and computational studies. Int J Biol Macromol. 2019 Apr 15;127:536-543. doi: 10.1016/j.ijbiomac.2019.01.083. Epub 2019 Jan 18.","parent_key":"BE0000530"}
{"ref-id":"A188027","pubmed-id":30442651,"citation":"Podoll T, Pearson PG, Evarts J, Ingallinera T, Bibikova E, Sun H, Gohdes M, Cardinal K, Sanghvi M, Slatter JG: Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. Drug Metab Dispos. 2019 Feb;47(2):145-154. doi: 10.1124/dmd.118.084459. Epub 2018 Nov 15.","parent_key":"BE0000530"}
{"ref-id":"A188027","pubmed-id":30442651,"citation":"Podoll T, Pearson PG, Evarts J, Ingallinera T, Bibikova E, Sun H, Gohdes M, Cardinal K, Sanghvi M, Slatter JG: Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. Drug Metab Dispos. 2019 Feb;47(2):145-154. doi: 10.1124/dmd.118.084459. Epub 2018 Nov 15.","parent_key":"BE0004879"}
{"ref-id":"A39998","pubmed-id":21402860,"citation":"Di Stefano AF, Rusca A, Loprete L, Droge MJ, Moro L, Assandri A: Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers. Antimicrob Agents Chemother. 2011 May;55(5):2122-8. doi: 10.1128/AAC.01504-10. Epub 2011 Mar 14.","parent_key":"BE0000530"}
{"ref-id":"A31586","pubmed-id":29042751,"citation":"Cinti F, Moffa S, Impronta F, Cefalo CM, Sun VA, Sorice GP, Mezza T, Giaccari A: Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date. Drug Des Devel Ther. 2017 Oct 3;11:2905-2919. doi: 10.2147/DDDT.S114932. eCollection 2017.","parent_key":"BE0000530"}
{"ref-id":"A19923","pubmed-id":15461448,"citation":"Lu WD, Atkins WM: A novel antioxidant role for ligandin behavior of glutathione S-transferases: attenuation of the photodynamic effects of hypericin. Biochemistry. 2004 Oct 12;43(40):12761-9.","parent_key":"BE0000530"}
{"ref-id":"A32659","pubmed-id":8185676,"citation":"Cheraghali AM, Kumar R, Wang L, Knaus EE, Wiebe LI: Synthesis, biotransformation, pharmacokinetics, and antiviral properties of 5-ethyl-5-halo-6-methoxy-5,6-dihydro-2'-deoxyuridine diastereomers. Biochem Pharmacol. 1994 Apr 29;47(9):1615-25.","parent_key":"BE0000530"}
{"ref-id":"A33071","pubmed-id":3378305,"citation":"Ishida S, Ichikawa T, Sakiya Y: Binding of glycyrrhetinic acid to rat plasma, rat serum albumin, human serum, and human serum albumin. Chem Pharm Bull (Tokyo). 1988 Jan;36(1):440-3.","parent_key":"BE0000530"}
{"ref-id":"A32571","pubmed-id":9146788,"citation":"Lambert JR, Midolo P: The actions of bismuth in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997 Apr;11 Suppl 1:27-33.","parent_key":"BE0000530"}
{"ref-id":"A31423","pubmed-id":28266779,"citation":"Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, Hjerpsted JB: Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017 Sep;19(9):1242-1251. doi: 10.1111/dom.12932. Epub 2017 May 5.","parent_key":"BE0000530"}
{"ref-id":"A32821","pubmed-id":18568054,"citation":"Swaminathan R: Magnesium metabolism and its disorders. Clin Biochem Rev. 2003 May;24(2):47-66.","parent_key":"BE0000530"}
{"ref-id":"A193065","pubmed-id":6831689,"citation":"Scott BJ, Bradwell AR: Identification of the serum binding proteins for iron, zinc, cadmium, nickel, and calcium. Clin Chem. 1983 Apr;29(4):629-33.","parent_key":"BE0000530"}
{"ref-id":"A192726","pubmed-id":23730875,"citation":"Bosca F, Tormos R: Behavior of drug excited states within macromolecules: binding of colchicine and derivatives to albumin. J Phys Chem B. 2013 Jun 27;117(25):7528-34. doi: 10.1021/jp402489j. Epub 2013 Jun 14.","parent_key":"BE0000530"}
{"ref-id":"A203912","pubmed-id":27307345,"citation":"Liao GJ, Clark AS, Schubert EK, Mankoff DA: 18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications. J Nucl Med. 2016 Aug;57(8):1269-75. doi: 10.2967/jnumed.116.175596. Epub 2016 Jun 15.","parent_key":"BE0000530"}